🏷

Classifications

Harrison's Part

👪

Inheritance

1

Autosomal dominant, typically de novo HP:0000006

White-Sutton syndrome is autosomal dominant and in most cases arises from a de novo POGZ variant. Inheritance from a heterozygous parent who has developmental delay and/or mild intellectual disability is documented but rare, so parental testing is required before counselling recurrence risk. Expressivity is markedly variable even within families, spanning learning difficulties to severe intellectual disability.

Autosomal dominant inheritance Expressivity: VARIABLE

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"White-Sutton syndrome is an autosomal dominant disorder typically caused by a de novo pathogenic variant. Most probands reported to date whose parents have undergone molecular genetic testing have the disorder as the result of a de novo POGZ pathogenic variant. Rarely, individuals with..."

GeneReviews states the autosomal dominant, predominantly de novo mechanism and the rare inherited exception with a mildly affected transmitting parent.

PMID:34645992 SUPPORT Human Clinical

"we identified 12 individuals from 10 families with pathogenic or likely pathogenic variants in POGZ (eight de novo and two inherited)"

Quantifies the de novo versus inherited split in a clinical series, documenting that familial transmission occurs.

?

Discussions and Knowledge Gaps

2

Do pathogenic POGZ alleles act uniformly through haploinsufficiency, or do stable NMD-escaping truncations produce additional dominant-negative or gain-of-function effects that explain their greater clinical severity?

KNOWLEDGE GAP OPEN whsus_allelic_mechanism

Attached to

pathophysiology#Pathogenic POGZ Variant Dysfunction

Heterozygous loss-of-function variants establish reduced POGZ activity as a major disease mechanism, but the strongest genotype-phenotype study found greater severity for truncations predicted to escape NMD and explicitly proposed dominant-negative or gain-of-function effects. That proposal is an inference from variant position and clinical severity, not a direct demonstration of mutant-transcript stability, truncated-protein abundance or altered chromatin occupancy. Resolving the allelic mechanism is important for interpreting genotype-severity associations and for deciding whether simple restoration of POGZ dosage would address all pathogenic allele classes.

Proposed experiments

Isogenic comparison of NMD-triggering and NMD-escaping POGZ alleles

whsus_isogenic_allelic_mechanism

Introduce representative NMD-triggering and NMD-escaping truncations into the same human iPSC background, differentiate them into neural progenitors and neurons, and compare allele-specific RNA, mutant-protein abundance, nuclear localisation, POGZ/HP1 chromatin occupancy, transcriptional output, neuronal differentiation and migration. Include correction of patient alleles and selective knockdown of the mutant transcript.

Decision criterion

Phenotypes proportional to total functional POGZ dosage and rescued by wild-type restoration would support haploinsufficiency; effects unique to NMD-escaping alleles that improve after mutant-selective knockdown would support an additional dominant-negative or gain-of-function mechanism.

Show evidence (1 reference)

PMID:35052493 SUPPORT Human Clinical

"Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ-associated neurodevelopmental disorders."

The authors explicitly frame the alternative allelic mechanism as a suggestion, identifying a material unresolved causal question rather than a demonstrated mechanism.

Does the reversibility of social deficits by compensatory inhibition of elevated neuronal excitability in the Pogz mouse translate to any tractable intervention in humans with White-Sutton syndrome?

HUMAN MODEL MISMATCH OPEN whsus_excitability_reversibility

Attached to

pathophysiology#Elevated Neuronal Excitability

The mouse result is unusual and important: it shows that at least one behavioural consequence of a developmental chromatin-regulator lesion is not fixed at birth but depends on an ongoing, pharmacologically addressable circuit state. If that held in humans it would change the therapeutic framing of the disorder from purely supportive to potentially modifiable. But there are no human data at all - no measurement of cortical excitability in individuals with POGZ variants, and no trial of any excitability-reducing agent for the social or cognitive phenotype. The mismatch is mechanistically meaningful because the human phenotype includes established structural brain malformations that the excitability model does not address, so even a true excitability contribution would explain only part of the picture. It is further complicated by direct disagreement between the two published Pogz mouse models: the knock-in model shows social DEFICITS rescued by inhibiting excitability, whereas the brain-specific conditional knockout reports INCREASED sociability alongside a cerebellar Purkinje cell defect. Any translational claim must account for that contradiction rather than generalising from one model.

Proposed experiments

Cortical excitability measurement in POGZ variant carriers

whsus_human_excitability_measurement

Use transcranial magnetic stimulation measures of cortical excitability and quantitative EEG in individuals with pathogenic POGZ variants versus matched neurodevelopmental controls.

Decision criterion

Demonstrating elevated cortical excitability in humans would justify a trial of an excitability-reducing agent; normal excitability would confine the mouse finding to that model.

Excitability phenotyping and rescue in patient-derived neurons

whsus_patient_ipsc_excitability

Extend the existing patient iPSC work to mature cortical neurons and test whether elevated excitability is present and whether the same compensatory inhibition used in the mouse normalises network activity.

Decision criterion

Reproduction and rescue in human neurons would bridge the model-to-human gap without requiring a clinical trial first.

Show evidence (2 references)

PMID:32103003 SUPPORT Model Organism

"Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice."

The finding whose human translation is the open question; it is mouse-only.

PMID:34645992 SUPPORT Human Clinical

"seizures, and structural brain malformations"

The human phenotype includes structural brain malformations, which an excitability-only model does not account for, so the mismatch is not merely one of missing data.

⚙

Pathophysiology

7

Pathogenic POGZ Variant Dysfunction

Heterozygous nonsense, frameshift and splice variants, and a minority of missense variants, in POGZ reduce or alter the function of a multidomain nuclear protein. The genotype-phenotype relationship is not a simple dosage gradient: missense variants are associated with milder phenotypes, while truncating variants predicted to ESCAPE nonsense-mediated decay produce the most severe phenotypes, and within that group variants in the proline-rich region are the most severe of all. The authors infer that a gain-of-function or dominant-negative effect from a stable truncated protein may contribute to the severe end of the spectrum, but this allelic mechanism has not been demonstrated experimentally.

POGZ hgnc:18801

chromatin binding GO:0003682 ⚠ ABNORMAL

Downstream

Loss of POGZ-HP1 Heterochromatin Repression Altered POGZ function compromises the HP1-dependent repressive activity that POGZ exerts at pericentric heterochromatin.

Premature Cell-Cycle Exit in Cortical Progenitors Independently of its transcriptional-repressor role, POGZ is required for normal mitotic progression, so its loss reduces the number of dividing cortical progenitors. Curated as a separate arm from the transcriptional node because the reported intermediates are mitotic (kinetochore assembly and chromosome segregation) rather than transcriptional.

Disrupted POGZ-Dependent Transcriptional Regulation Altered POGZ function perturbs its transcriptional-regulatory role in the nucleus.

Show evidence (3 references)

PMID:34645992 SUPPORT Human Clinical

"White-Sutton syndrome (WHSUS) is a neurodevelopmental disorder caused by heterozygous loss-of-function variants in POGZ."

Establishes heterozygous POGZ loss-of-function variants as a major cause of the disorder, while the neutral node name also accommodates pathogenic missense alleles and unresolved effects of NMD-escaping truncations.

PMID:35052493 SUPPORT Human Clinical

"Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001). Within this group, variants in the prolin-rich region of the POGZ protein were associated with the most severe..."

Provides the quantitative genotype-phenotype correlation underlying the non-simple-dosage claim in this node.

PMID:35052493 SUPPORT Human Clinical

"Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ-associated neurodevelopmental disorders."

The gain-of-function/dominant-negative interpretation is offered by the authors as a suggestion inferred from statistical association rather than demonstrated functionally, so it is curated as partial support.

Loss of POGZ-HP1 Heterochromatin Repression

POGZ localises to pericentric heterochromatin in the same distribution as HP1-alpha and represses transcription in a dual-luciferase reporter assay. That repression is HP1-dependent: an H840A substitution in the HP1-binding zinc-finger-like (HPZ) domain, which abolishes the POGZ-HP1-alpha interaction, also abolishes repression. The HP1-binding step is therefore the molecular mechanism by which POGZ acts as a negative regulator of transcription, and is the specific activity lost in White-Sutton syndrome. The evidence is in vitro (HEK293 reporter assay, N2A immunofluorescence), so this node is curated at provisional confidence.

heterochromatin formation GO:0031507 ⚠ ABNORMAL

transcription corepressor activity GO:0003714 ↓ DECREASED

Downstream

Disrupted POGZ-Dependent Transcriptional Regulation Loss of the HP1-dependent repressive activity is the molecular basis for the transcriptional dysregulation - most conspicuously gene upregulation - seen when POGZ function is lost.

Show evidence (3 references)

PMID:33203851 SUPPORT In Vitro

"POGZ localizes to pericentric chromatin and represses transcription depending on HPZ."

States the localisation and the HPZ dependence of repression that this node represents.

PMID:33203851 SUPPORT In Vitro

"To test if the interaction with HP1 is essential for transcription repression, we used POGZ with H840A mutation in the HPZ domain"

Describes the HPZ-domain point mutation used to isolate the HP1-binding requirement.

PMID:33203851 SUPPORT In Vitro

"POGZ functions as a negative regulator of transcription depending on the interaction with HP1 proteins."

The authors' conclusion that POGZ-mediated repression requires the HP1 interaction, which is the claim this node asserts.

Disrupted POGZ-Dependent Transcriptional Regulation

POGZ is a multidomain nuclear protein that binds chromatin and participates in transcriptional regulation. Loss of normal POGZ function therefore perturbs the transcriptional programs it controls in the developing nervous system, which is the proximate step linking the genetic lesion to abnormal cortical development.

regulation of DNA-templated transcription GO:0006355 ⚠ ABNORMAL

Downstream

Impaired Cortical Neuronal Development Perturbed transcriptional output in neural progenitors and developing neurons impairs cortical development.

Cerebellar Purkinje Cell Circuit Dysfunction Loss of POGZ's negative transcriptional regulation produces the largest gene upregulation in cerebellum, with a corresponding Purkinje cell defect.

Show evidence (4 references)

PMID:31136090 SUPPORT Human Clinical

"POGZ (# 614787) encodes a multidomain nuclear protein involved in transcriptional regulation and its defective function has been recently associated with a syndromic neurodevelopmental disorder, known as White-Sutton syndrome (# 616364)."

Establishes POGZ's identity as a multidomain nuclear transcriptional regulator and links defective function to White-Sutton syndrome, confirming the OMIM identity (616364) that matches the MONDO xref.

PMID:32103003 SUPPORT Model Organism

"Here, we show that POGZ regulates neuronal development and that ASD-related de novo mutations impair neuronal development in the developing mouse brain"

Demonstrates in the developing mouse brain that POGZ regulates neuronal development and that disease-associated variants impair it.

PMID:32103003 SUPPORT In Vitro

"impair neuronal development in the developing mouse brain and induced pluripotent cell lines from an ASD patient"

The same finding was reproduced in induced pluripotent cell lines from a patient, providing the human cellular arm; split from the mouse item so each carries a single evidence source.

+ 1 more reference

Premature Cell-Cycle Exit in Cortical Progenitors

In the embryonic (E15.5) cerebral cortex of Pogz-deficient mice the number of pHH3-positive mitotic cells is significantly reduced and the Tbr2-positive intermediate-progenitor layer is correspondingly expanded, while the Pax6-positive apical-progenitor layer is unchanged. The authors interpret this as accelerated exit from the cell cycle - a shift from symmetric proliferative to asymmetric differentiative division - which depletes the progenitor pool available to generate cortical neurons. The finding is mouse-only, so this node is curated at provisional confidence.

neural progenitor cell CL:0011020

cell proliferation in forebrain GO:0021846 ↓ DECREASED mitotic cell cycle GO:0000278 ⚠ ABNORMAL

Downstream

Impaired Cortical Neuronal Development Early depletion of the cycling progenitor pool reduces the neurons available to build the cortex, which is the developmental lesion the downstream node represents.

Show evidence (3 references)

PMID:33203851 SUPPORT Model Organism

"we stained the sections for phospho-histone H3 (pHH3), which marks mitotic cells with condensed chromosomes"

Identifies the mitotic marker used to quantify dividing progenitors in the embryonic cortex.

PMID:33203851 SUPPORT Model Organism

"Our study shows that depletion of POGZ results in accelerated exit from the cell cycle in the developing cerebral cortex and a reduction in the number of cells in mitosis, which is consistent with the premature mitotic exit observed when POGZ was knockdown in human cells"

States the reduced mitotic index and accelerated cell-cycle exit in the developing cortex that this node represents, and notes concordance with human-cell knockdown.

PMID:33203851 SUPPORT Model Organism

"POGZ was previously found to be essential for normal kinetochore assembly, mitotic chromosome segregation, and for normal mitotic progression"

Provides the known mitotic function of POGZ that makes the reduced progenitor mitosis mechanistically interpretable.

Impaired Cortical Neuronal Development

Disease-associated de novo POGZ variants impair neuronal development in the developing mouse brain and in induced pluripotent cell lines derived from a patient. The consequence in the mature animal is impaired cortical network function, which is the cellular substrate proposed for the cognitive and behavioural phenotype.

neural progenitor cell CL:0011020 cerebral cortex neuron CL:0010012

cerebral cortex neuron differentiation GO:0021895 ⚠ ABNORMAL

Experimental models

Q1042R POGZ patient-derived iPSC neural model IPSC DERIVED MODEL Models impaired neuronal differentiation and migration in human patient-derived neural cells.

Downstream

Elevated Neuronal Excitability Abnormal cortical development yields neurons with elevated intrinsic excitability.

Intellectual Disability Impaired cortical development underlies the cognitive impairment.

Structural Brain Malformation The same developmental lesion produces the structural brain abnormalities documented on imaging.

Seizures Abnormal cortical development is the presumed substrate for the epilepsy; the intermediates are not established and no excitation/inhibition-imbalance claim is asserted.

Show evidence (4 references)

PMID:32103003 SUPPORT In Vitro

"We established iPSC lines using immortalized B cells obtained from that patient and an unaffected healthy control (Supplementary Fig. 6) and differentiated each iPSC lines into NSCs."

Establishes the patient-derived and control human iPSC neural-stem-cell system used to test the cellular developmental phenotype.

PMID:32103003 SUPPORT In Vitro

"the neuronal differentiation is impaired in patient-derived NSCs."

Directly supports impaired neuronal differentiation in the patient-derived human neural model.

PMID:32103003 SUPPORT Model Organism

"Our results provide insight into how de novo mutations on high-confidence ASD genes lead to impaired mature cortical network function, which underlies the cellular pathogenesis of NDDs, including ASD."

States the impaired-mature-cortical-network outcome that this node represents.

+ 1 more reference

Cerebellar Purkinje Cell Circuit Dysfunction

A second, independent mouse model - brain-specific conditional Pogz knockout - localises the strongest transcriptional consequence of Pogz loss to the cerebellum and shows a corresponding physiological defect: reduced simple- and complex-spike firing frequency and increased inhibitory synaptic input amplitude in Purkinje cells. This model also reproduces microcephaly and growth impairment, matching the human phenotype. It is curated as a parallel arm to the cortical node rather than subsumed into it, because the two models implicate different circuits and, notably, report opposite social phenotypes.

Purkinje cell CL:0000121

Downstream

Microcephaly The same conditional-knockout model that shows the cerebellar defect also reproduces microcephaly and growth impairment.

Show evidence (3 references)

PMID:33203851 SUPPORT Model Organism

"Physiologically, Pogz deficiency is associated with a reduction in the firing frequency of simple and complex spikes and an increase in amplitude of the inhibitory synaptic input in cerebellar Purkinje cells."

Direct electrophysiological characterisation of the Purkinje cell defect in the conditional knockout.

PMID:33203851 SUPPORT Model Organism

"We demonstrate that Pogz deficient mice show microcephaly, growth impairment, increased sociability, learning and motor deficits, mimicking several of the human symptoms."

Establishes construct and partial face validity of this model, and records that it shows INCREASED sociability, the opposite direction to the other published Pogz mouse.

PMID:33203851 SUPPORT Model Organism

"Our findings support a mechanism linking heterochromatin dysregulation to cerebellar circuit dysfunction and behavioral abnormalities in ASD."

States the heterochromatin-to-cerebellar-circuit mechanism this node represents.

Elevated Neuronal Excitability

In the heterozygous Pogz mouse, social deficits can be treated by compensatory inhibition of elevated cell excitability, identifying raised neuronal excitability as a functionally causal and pharmacologically reversible node rather than a fixed developmental endpoint. This is the single most therapeutically interesting finding in the disorder and is the reason a reversibility discussion is recorded. It is currently mouse-only.

cerebral cortex neuron CL:0010012

Downstream

Autistic Behavior Elevated excitability underlies the social deficits in the mouse model, the behavioural correlate of the human autistic phenotype.

Show evidence (1 reference)

PMID:32103003 SUPPORT Model Organism

"Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice."

Demonstrates that elevated neuronal excitability is causal for the social phenotype in the mouse and that the deficit is pharmacologically reversible in that model.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

27

Cardiovascular 1

Congenital Heart Disease OCCASIONAL Abnormal heart morphology HP:0001627

Show evidence (2 references)

PMID:37016333 SUPPORT Human Clinical

"A review of the current literature revealed 18 cases of White-Sutton syndrome with POGZ variants and congenital heart disease, and we summarize their clinical features in this study."

Quantifies 18 previously reported cases with congenital heart disease, which against a published caseload of about 80 is consistent with an OCCASIONAL band.

PMID:37016333 SUPPORT Human Clinical

"The relationship between congenital heart disease and White-Sutton syndrome as described in both the GeneReview and OMIM databases (#616,364) remains unclear."

Records that the association was not established in the authoritative databases at the time, which is why this phenotype is curated as emerging and the evidence as partial.

Digestive 4

Gastrointestinal Involvement VERY_FREQUENT Abnormality of the gastrointestinal tract HP:0011024

Show evidence (2 references)

PMID:31782611 SUPPORT Human Clinical

"GI involvement occurred in the majority (17/19, 89%) of the individuals for whom information was available."

Quantifies any gastrointestinal involvement at 89%, supporting the VERY_FREQUENT band for the broad phenotype.

PMID:34529370 SUPPORT Human Clinical

"feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females"

GeneReviews lists feeding and gastrointestinal problems among the commonly reported additional features.

Feeding Difficulties FREQUENT HP:0011968

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Eleven (11/18, 61%) had a history of feeding difficulties."

Quantifies feeding difficulties at 61%, supporting the FREQUENT band.

Dysphagia FREQUENT HP:0002015

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Nine subjects (9/17, 53%) had dysphagia/swallowing problems"

Quantifies dysphagia or swallowing problems at 53%, supporting the FREQUENT band.

Constipation FREQUENT HP:0002019

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"eight (8/17, 47%) had constipation."

Quantifies constipation at 47%, supporting the FREQUENT band.

Ear 1

Sensorineural Hearing Loss FREQUENT Sensorineural hearing impairment HP:0000407

Show evidence (2 references)

PMID:34645992 SUPPORT Human Clinical

"increased risk of obesity, visual defects, craniofacial dysmorphism, sensorineural hearing loss, feeding problems, seizures, and structural brain malformations"

Sensorineural hearing loss is established in a pooled analysis of 101 individuals.

PMID:34529370 SUPPORT Human Clinical

"refractive errors and strabismus, hearing loss, sleep disturbance"

GeneReviews lists hearing loss among the commonly reported additional features.

Eye 1

Strabismus FREQUENT HP:0000486

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"Additional features commonly reported include seizures, refractive errors and strabismus"

GeneReviews lists strabismus among the commonly reported additional features.

PMID:31782611 SUPPORT Human Clinical

"Other common problems included ocular abnormalities, hearing loss and gait abnormalities."

Confirms ocular abnormalities as a common problem in an independent series.

Genitourinary 1

Genitourinary Anomalies OCCASIONAL Abnormality of the genitourinary system HP:0000119

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"mild genital abnormalities in males, and urinary tract involvement in both males and females"

GeneReviews lists genital and urinary tract involvement among the commonly reported additional features.

PMID:31782611 SUPPORT Human Clinical

"as well as genitourinary anomalies"

Confirms genitourinary anomalies as over-represented in this series.

Head and Neck 2

Microcephaly FREQUENT HP:0000252

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Common facial features included microcephaly, broad forehead, midface hypoplasia, triangular mouth, broad nasal root and flat nasal bridge."

Microcephaly is listed among the common facial features of a 22-person series, supporting a FREQUENT band.

Midface Retrusion FREQUENT HP:0011800

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"microcephaly, broad forehead, midface hypoplasia, triangular mouth"

Midface hypoplasia is listed among the common facial features of this series.

Musculoskeletal 1

Hypotonia FREQUENT HP:0001252

Show evidence (1 reference)

PMID:34529370 SUPPORT Human Clinical

"developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems"

GeneReviews lists hypotonia among the characterising features; the unquantified listing maps to the FREQUENT band.

Nervous System 10

Intellectual Disability FREQUENT HP:0001249

Show evidence (2 references)

PMID:33277917 SUPPORT Human Clinical

"Among the 19 patients, 14 patients exhibited ID (six mild, five moderate and three severe)."

Quantifies frank intellectual disability at 14 of 19 (74%) in an unbiased national cohort, which falls in the FREQUENT (30-79%) band. The remaining 5 individuals had learning disabilities rather than intellectual disability, so the band is set on the HP:0001249 claim itself and not widened to cognitive impairment generally.

PMID:33277917 SUPPORT Human Clinical

"This study reveals that the cognitive phenotype of patients with POGZ pathogenic variants can range from learning disabilities to severe ID."

Establishes the breadth of the cognitive range, which is why the entry does not assert a single severity level.

Global Developmental Delay VERY_FREQUENT HP:0001263

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems."

GeneReviews lists developmental delay among the defining features of the syndrome.

PMID:34645992 SUPPORT Human Clinical

"Most individuals had delayed development and/or intellectual disability."

Confirms delayed development in most individuals of a 12-person series combined with 89 previously reported individuals.

Speech and Language Delay VERY_FREQUENT Delayed speech and language development HP:0000750

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"We observed a broad spectrum of intellectual disability and/or developmental delay with or without autism, and speech delay in all individuals."

Speech delay was present in all 22 individuals of this series, supporting a VERY_FREQUENT band.

Motor Delay VERY_FREQUENT HP:0001270

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Some degree of motor delay was reported for 19/22 (86%) patients (delay was questionable in one additional case)."

Quantifies motor delay at 86%, supporting the VERY_FREQUENT band.

Autistic Behavior FREQUENT HP:0000729

Show evidence (3 references)

PMID:34529370 SUPPORT Human Clinical

"hypotonia, autism spectrum disorder, and other behavioral problems"

GeneReviews lists autism spectrum disorder among the characterising features of the syndrome.

PMID:31782611 SUPPORT Human Clinical

"We observed a broad spectrum of intellectual disability and/or developmental delay with or without autism"

Explicitly notes that autism is present in some but not all individuals, which is why the band is FREQUENT rather than VERY_FREQUENT.

PMID:33277917 SUPPORT Human Clinical

"One patient evaluated for autism was found to have moderate autism spectrum disorder."

Documents that only one individual in this 19-person cohort underwent formal autism evaluation, sourcing the statement that formal ascertainment is incomplete.

Behavioral Problems FREQUENT Atypical behavior HP:0000708

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"autism spectrum disorder, and other behavioral problems"

GeneReviews lists other behavioural problems alongside autism among the characterising features.

PMID:33277917 SUPPORT Human Clinical

"White-Sutton syndrome is a rare developmental disorder characterized by global developmental delay, intellectual disabilities (ID), and neurobehavioral abnormalities"

Confirms neurobehavioural abnormalities as a defining component of the syndrome.

Seizures FREQUENT HP:0001250

Onset: INFANTILE; 1.0-4.0y

Show evidence (3 references)

PMID:34529370 SUPPORT Human Clinical

"Additional features commonly reported include seizures, refractive errors and strabismus, hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females."

GeneReviews describes seizures as commonly reported, which maps to the FREQUENT band.

PMID:31136090 SUPPORT Human Clinical

"we detected that epilepsy onset is mostly during infancy (1-4 years of age), with both focal and generalized seizures. EEGs reveal that epileptic abnormalities mainly are localized in the frontal regions, and seizure control might be reached with one or multiple antiepileptic drugs."

Characterises the electroclinical phenotype, onset window and treatability of POGZ-related epilepsy.

PMID:31136090 SUPPORT Human Clinical

"While originally epileptic seizures were unreported, it seems that epilepsy represents a recurrent feature in affected subjects."

Documents that epilepsy was missed in the original phenotype descriptions and is now recognised as recurrent, which is a surveillance-relevant point.

Sleep Disturbance FREQUENT HP:0002360

Show evidence (2 references)

PMID:38350721 SUPPORT Human Clinical

"Sleep disturbances were observed in 52% of patients, and being obese was not observed as a risk factor for sleep problems."

Quantifies sleep disturbance at 52% across previously described POGZ variant carriers, squarely in the FREQUENT (30-79%) band, and shows it is not driven by obesity.

PMID:34529370 SUPPORT Human Clinical

"hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems"

GeneReviews lists sleep disturbance among the commonly reported additional features.

Obstructive Sleep Apnea FREQUENT HP:0002870

Show evidence (2 references)

PMID:31782611 SUPPORT Human Clinical

"A validated sleep disordered breathing questionnaire identified symptoms of obstructive sleep apnea in 4/12 (33%) individuals."

A questionnaire found obstructive-sleep-apnoea symptoms in 33%, but did not confirm all cases polysomnographically; it therefore only partially supports the phenotype-specific rate.

PMID:34529370 SUPPORT Human Clinical

"hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems"

GeneReviews identifies sleep apnoea specifically as the characteristic sleep disturbance.

Gait Abnormality FREQUENT Gait disturbance HP:0001288

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Other common problems included ocular abnormalities, hearing loss and gait abnormalities."

Gait abnormalities are described as a common problem in a 22-person series, mapping to the FREQUENT band.

Growth 1

Increased Body Weight FREQUENT HP:0004324

Show evidence (2 references)

PMID:31782611 SUPPORT Human Clinical

"Overall, 6/16 (37.5%) were overweight or obese."

Directly quantifies overweight or obesity at 37.5%, supporting the FREQUENT band without inferring a threshold frequency from a mean BMI z-score.

PMID:34645992 SUPPORT Human Clinical

"increased risk of obesity"

Independently confirms increased obesity risk in a pooled analysis.

Other 5

Refractive Error FREQUENT Abnormality of refraction HP:0000539

Show evidence (3 references)

PMID:34529370 SUPPORT Human Clinical

"seizures, refractive errors and strabismus, hearing loss"

GeneReviews lists refractive errors among the commonly reported additional features.

PMID:34645992 SUPPORT Human Clinical

"The results demonstrate WHSUS is associated with variable developmental delay or intellectual disability, increased risk of obesity, visual defects, craniofacial dysmorphism, sensorineural hearing loss, feeding problems, seizures, and structural brain malformations."

Confirms visual defects as an established association in a pooled analysis of 101 individuals.

PMID:34645992 SUPPORT Human Clinical

"Our series includes further individuals with rod-cone dystrophy, cleft lip and palate, congenital diaphragmatic hernia, and duplicated renal drainage system, suggesting these are rare complications of WHSUS."

Identifies rod-cone dystrophy explicitly as a rare complication, sourcing that claim in this phenotype's description.

Episodic Vomiting FREQUENT HP:0002572

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Cyclic vomiting was reported in 6/16 (37.5%) of subjects"

Quantifies recurrent cyclic vomiting at 37.5%, supporting the FREQUENT band and mapping it to the broader HP episodic-vomiting concept.

Male Genital Abnormalities OCCASIONAL Abnormality of the male genitalia HP:0010461

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Mild male genital anomalies were reported in four of 14 (28.6%) male subjects including undescended testes, hypoplastic scrotum, hypoplastic testes and micropenis, and redundant foreskin with phimosis."

Quantifies the broad male-genital phenotype at 28.6%, supporting the OCCASIONAL band and enumerating its reported manifestations.

Structural Brain Malformation OCCASIONAL Abnormal brain morphology HP:0012443

Show evidence (2 references)

PMID:34645992 SUPPORT Human Clinical

"seizures, and structural brain malformations"

Establishes structural brain malformations as an association in a pooled analysis; no numerator is given, so the band is set conservatively.

PMID:31136090 SUPPORT Human Clinical

"major brain MR features include cortical and cerebellar atrophy, delayed myelination, and brainstem hypoplasia"

Enumerates the specific MRI abnormalities seen in the subset with epilepsy.

Broad Forehead FREQUENT HP:0000337

Show evidence (1 reference)

PMID:31782611 SUPPORT Human Clinical

"Common facial features included microcephaly, broad forehead, midface hypoplasia, triangular mouth, broad nasal root and flat nasal bridge."

A broad forehead is listed among the common facial features of this series.

🧬

Genetic Associations

1

POGZ (Causal - heterozygous pathogenic variants)

Gene: POGZ hgnc:18801 relationship_type: CAUSATIVE

Show evidence (3 references)

PMID:31782611 SUPPORT Human Clinical

"Here we report the clinical features of 22 individuals with 21 unique loss of function POGZ variants."

Documents the loss-of-function variant spectrum across a 22-person series with near-unique variants.

PMID:35052493 SUPPORT Human Clinical

"Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001)."

Establishes the statistically supported genotype-severity relationship, including the NMD-escape effect.

PMID:34645992 SUPPORT Human Clinical

"Our work further delineates the phenotypic spectrum of WHSUS highlighting the variable severity of this disorder and the observation of familial pathogenic POGZ variants."

Documents both the variable severity and the occurrence of familial (inherited) pathogenic POGZ variants.

💊

Medical Actions

4

Multidisciplinary Standard-of-Care Management

Action: supportive care Ontology label: Supportive Care NCIT:C15747

There is no disease-modifying therapy. Developmental delay and intellectual disability, speech and language acquisition, behavioural issues, seizures, refractive errors and strabismus, hearing impairment, sleep disturbance, feeding and gastrointestinal issues, and genitourinary problems are each managed by the relevant specialists per standard care, with follow-up of the common manifestations at every clinic visit.

Show evidence (2 references)

PMID:34529370 SUPPORT Human Clinical

"Developmental delay/intellectual disability, speech and language acquisition, behavioral issues, seizures, refractive errors and strabismus, hearing impairment, sleep disturbance, feeding and gastrointestinal issues, and genitourinary problems are managed by specialists per standard care."

GeneReviews defines the standard of care as specialist-led symptomatic management across the affected systems.

PMID:34529370 SUPPORT Human Clinical

"Surveillance: Follow up of the common manifestations at each clinic visit."

States the recommended surveillance regimen.

Speech and Language Specialist Care

Action: speech and language therapy Ontology label: Speech Language Therapy NCIT:C159273

Speech and language acquisition is the developmental domain most consistently affected. GeneReviews places it within specialist standard care, but the available review does not define a syndrome-specific therapy protocol or quantify treatment response.

Target Phenotypes: Delayed speech and language development HP:0000750

Show evidence (1 reference)

PMID:34529370 SUPPORT Human Clinical

"speech and language acquisition, behavioral issues, seizures"

GeneReviews supports specialist management of speech and language acquisition, but the excerpt does not evaluate a specific speech-language therapy protocol or outcome.

Antiseizure Medication

Action: Pharmacotherapy NCIT:C15986

Epilepsy is managed with standard antiseizure medication. A disorder-focused review reports that seizure control may be reached with one or multiple agents, without establishing comparative efficacy for any regimen.

Target Phenotypes: Seizure HP:0001250

Show evidence (1 reference)

PMID:31136090 SUPPORT Human Clinical

"seizure control might be reached with one or multiple antiepileptic drugs"

Reports that seizure control may be achieved with one or multiple antiseizure medications, without comparing regimens.

Genetic Counseling

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Counselling covers the autosomal dominant, predominantly de novo mechanism, the documented but rare inheritance from a mildly affected parent (so both parents should be tested before recurrence risk is quoted as low), and the availability of prenatal and preimplantation genetic testing once the familial variant is known.

Show evidence (1 reference)

PMID:34529370 SUPPORT Human Clinical

"Once the POGZ pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing are possible."

GeneReviews states the reproductive testing options that counselling addresses.

🔬

Diagnosis

2

Molecular Genetic Testing for POGZ (Positive in affected individuals)

The diagnosis is established by identifying a heterozygous pathogenic POGZ variant in an individual with suggestive findings, typically on exome or genome sequencing or a neurodevelopmental gene panel. Because the cognitive phenotype extends down to learning difficulties, the authors of the French cohort argue that children with learning disabilities may benefit from next-generation sequencing rather than being excluded from testing. In one diagnostic laboratory, POGZ variants accounted for approximately 0.14% of clinical exomes referred for neurological indications; this is a referral yield, not a population prevalence estimate.

molecular genetic testing NCIT:C19770

Show evidence (3 references)

PMID:34529370 SUPPORT Human Clinical

"The diagnosis of White-Sutton syndrome is established in a proband with suggestive findings and a heterozygous pathogenic variant in POGZ identified by molecular genetic testing."

GeneReviews states the molecular diagnostic criterion.

PMID:33277917 SUPPORT Human Clinical

"It highlights that pathogenic variations in the same genes can be reported in a large spectrum of neurocognitive profiles, and that children with learning disabilities could benefit from next generation sequencing techniques."

Supports extending genomic testing to milder learning-disability presentations, which is a direct diagnostic-strategy implication of the phenotypic range.

PMID:31782611 SUPPORT Human Clinical

"Analysis of the Baylor Genetics clinical laboratory database revealed that POGZ variants were implicated in approximately 0.14% of cases who underwent clinical exome sequencing for neurological indications with or without involvement of other body systems."

Records the diagnosis yield in an ascertained referral laboratory while explicitly keeping it separate from population occurrence.

Sleep-Disordered-Breathing Assessment

Sleep symptoms should be assessed as part of routine specialist follow-up. In one small cohort, a validated sleep-disordered-breathing questionnaire identified obstructive-sleep-apnoea symptoms in 4 of 12 individuals; this establishes a screening observation, not the accuracy of a diagnostic test or a syndrome-specific treatment protocol.

Results: Questionnaire symptoms of obstructive sleep apnea were identified in 4 of 12 individuals screened.

Show evidence (2 references)

PMID:31782611 SUPPORT Human Clinical

"A validated sleep disordered breathing questionnaire identified symptoms of obstructive sleep apnea in 4/12 (33%) individuals."

Documents questionnaire-based detection of obstructive-sleep-apnoea symptoms while not claiming polysomnographic confirmation or management efficacy.

PMID:34529370 SUPPORT Human Clinical

"Surveillance: Follow up of the common manifestations at each clinic visit."

Supports routine follow-up of common manifestations, including the sleep disturbance identified elsewhere in the same GeneReviews abstract, but does not prescribe a sleep-specific protocol.

🩻

Imaging Findings

1

Structural brain abnormalities on MRI OCCASIONAL

Reported MRI abnormalities include cortical and cerebellar atrophy, delayed myelination and brainstem hypoplasia. These findings are variable and supportive, not diagnostic.

Mri

Abnormal brain morphology HP:0012443 brain UBERON:0000955 Abnormal brain morphology HP:0012443

Show evidence (2 references)

PMID:34645992 SUPPORT Human Clinical

"seizures, and structural brain malformations"

Establishes structural brain malformations as part of the reported clinical spectrum.

PMID:31136090 SUPPORT Human Clinical

"major brain MR features include cortical and cerebellar atrophy, delayed myelination, and brainstem hypoplasia"

Enumerates the MRI appearances represented by this imaging finding.

📈

Progression

1

Neurodevelopmental presentation and clinical recognition

Age: First evaluation from one week to 28 years in one reported cohort

The disorder is developmental, but age at recognition is broad and diagnostic delay can be prolonged. One cohort reported first medical evaluation from the neonatal period to adulthood and a delay from first concern to molecular diagnosis of more than 15 years in some individuals. Published cohorts do not yet define adult longitudinal progression, mortality or life expectancy.

Show evidence (2 references)

PMID:31782611 SUPPORT Human Clinical

"Ages at first medical evaluation ranged from one week (presenting with birth defects) to 28 years (subject seen for calcinosis cutis, and noted to have mild intellectual disability and polydactyly). Median age at diagnosis was eight years, and the time from initial concern to diagnosis ranged..."

Directly supports the broad recognition range and prolonged diagnostic delay; it does not establish the natural history of manifestations in adulthood.

PMID:34529370 SUPPORT Human Clinical

"White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems."

Establishes the developmental nature of the presentation but does not provide longitudinal adult-course data.

📊

Prevalence

1

Published individuals worldwide

Cases In Literature Ultra Rare

Case counts rose from over 50 reported worldwide in 2019 to about 80 by 2023; a 2022 genotype-phenotype analysis pooled 117 individuals. No population prevalence estimate has been established.

Show evidence (2 references)

PMID:35052493 SUPPORT Human Clinical

"Overall, 117 POGZ patients' genotype and phenotype data were included in the analysis, including 12 novel patients."

Quantifies the pooled published caseload as of 2022, supporting an ultra-rare classification.

PMID:37016333 SUPPORT Human Clinical

"To date, 80 cases have been reported in the literature; however, the phenotypic characterizations remain incomplete."

Independently reports the published caseload and notes that phenotypic characterisation is still incomplete.

🔀

Differential Diagnoses

6

Conditions with similar clinical presentations that must be differentiated from White-Sutton Syndrome:

Other Syndromic Intellectual Disability with Autism

Overlapping Features White-Sutton syndrome has no pathognomonic feature; the combination of speech-predominant developmental delay, autism, hypotonia, ocular findings and increased BMI is suggestive but the diagnosis is molecular. Broad genomic testing rather than targeted single-gene testing is the practical approach.

Show evidence (2 references)

PMID:38019139 SUPPORT Human Clinical

"White-Sutton Syndrome is one of the rare neurodevelopmental disorder inherited in an autosomal dominant manner, mainly caused by de novo mutations in the POGZ gene and shows many phenotypic signs such as intellectual disability, Autism Spectrum Disorder and other spectra."

A literature review specifically framed around discriminative features concludes the presentation is a nonspecific intellectual-disability/autism spectrum, which is why the differential is broad and the diagnosis molecular.

PMID:38019139 SUPPORT Human Clinical

"The results of Whole Exome Sequencing test, performed for the patient, declared the presence of a de novo mutation in POGZ gene and confirmed the White-Sutton Syndrome diagnosis."

Illustrates the practical point that broad sequencing rather than clinical discrimination establishes the diagnosis.

Nonsyndromic Autism Spectrum Disorder

Overlapping Features POGZ is one of the most recurrently de novo mutated genes in autism cohorts, so individuals may first be labelled with idiopathic ASD; the associated dysmorphism, ocular, auditory, gastrointestinal and genitourinary findings should prompt genomic testing.

Helsmoortel-Van der Aa Syndrome (ADNP) MONDO:0014379

Overlapping Features The most mechanistically apposite differential. ADNP, like POGZ, is a high-confidence de novo autism gene whose product participates in HP1-binding chromatin complexes, and the two disorders converge clinically on speech-predominant developmental delay, autism, hypotonia, feeding difficulty, visual problems and a recognisable but non-specific facial gestalt. The disorders are separated by molecular testing, not by phenotype.

Distinguishing Features

The causative gene - ADNP versus POGZ - identified by exome or genome sequencing is the only reliable discriminator; the two are not separable on clinical grounds.

Show evidence (1 reference)

PMID:33203851 SUPPORT Other

"heterochromatin formation, or participate in complexes that bind different isotypes of the human heterochromatin protein 1 (HP1) (e.g. SUV420H113, ADNP14 and POGZ15–19)."

The paper explicitly names ADNP and POGZ among high-confidence ASD-risk genes linked to HP1-binding chromatin biology, supporting mechanistic proximity while not establishing clinical indistinguishability.

Other Chromatinopathy-Associated Neurodevelopmental Disorders

Overlapping Features CHAMP1, CHD8, KBG syndrome (ANKRD11), Coffin-Siris syndrome (BAF complex) and Wiedemann-Steiner syndrome (KMT2A) all produce syndromic intellectual disability with autism through lesions in chromatin regulators and overlap substantially with White-Sutton syndrome. They are listed as a group because none is separable from POGZ-related disease on clinical grounds; exome or genome sequencing is the discriminator.

Smith-Magenis Syndrome (RAI1)

Overlapping Features Shares intellectual disability, behavioural problems including self-injury, sleep disturbance and obesity; distinguished by molecular testing.

Prader-Willi Syndrome

Overlapping Features Shares hypotonia, developmental delay, behavioural difficulties and obesity; distinguished by methylation testing of the 15q11-q13 region.

🔬

Clinical Trials

1

NCT07380594 RECRUITING

PSY-POGZ (CHU Dijon Bourgogne), an observational descriptive study of psychiatric symptoms in White-Sutton syndrome. It is not an interventional trial - no disease-modifying therapy exists - but it is the only registered study specific to the disorder and targets the anxiety/behavioural dimension that is under-characterised relative to the developmental phenotype.

Target Phenotypes: Anxiety HP:0000739 Autistic behavior HP:0000729 Attention deficit hyperactivity disorder HP:0007018

Show evidence (2 references)

clinicaltrials:NCT07380594 SUPPORT Human Clinical

"Psychiatrically, anxiety seems to predominate and manifest itself broadly in the form of generalised anxiety disorder, phobic disorder or obsessive-compulsive disorder. Some patients may also present with autism spectrum disorders, behavioural disorders and attention disorders with or without..."

States the psychiatric phenotype the study is designed to characterise.

clinicaltrials:NCT07380594 SUPPORT Human Clinical

"It is therefore essential to define more precisely the psychological characteristics of patients and the psychiatric comorbidities that may be associated with this condition in order to adapt behavioural, environmental and therapeutic management strategies."

States the study objective, which is descriptive characterisation rather than intervention.

🧫

Experimental Models

1

Q1042R POGZ patient-derived iPSC neural model IPSC_DERIVED_MODEL

Patient-derived neural stem cells carrying POGZ p.Gln1042Arg showed reduced early neuronal differentiation, increased proliferation and attenuated radial migration relative to control cells. The donor was ascertained for sporadic ASD rather than as part of a White-Sutton syndrome cohort, so this is an informative human POGZ-neurodevelopmental-disorder model rather than a representative model of the full syndrome or its allelic spectrum.

Organism

human NCBITaxon:9606

Cell source

Immortalized B cells from a person with sporadic ASD and de novo POGZ p.Gln1042Arg, and from an unaffected control, reprogrammed to iPSCs

Culture

iPSC differentiation to neural stem cells, followed by early neuronal differentiation and radial-migration assays

Publication

PMID:32103003

Pathograph links

Impaired Cortical Neuronal Development Models impaired neuronal differentiation and migration in human patient-derived neural cells.

Show evidence (1 reference)

PMID:32103003 SUPPORT In Vitro

"The proportion of MAP2+ neurons was significantly lower in the patient-derived NSCs than in the control NSCs, suggesting that neuronal differentiation is impaired in the patient-derived NSCs"

Directly links the patient-derived neural model to impaired neuronal differentiation.

Findings

Patient-derived neural stem cells showed impaired early neuronal differentiation.

"the neuronal differentiation is impaired in patient-derived NSCs"

Radial migration of young patient-derived neurons was attenuated.

"the radial migration of young neurons was significantly attenuated in the patient-derived NSCs"

Patient-derived neural stem cells showed increased proliferation relative to control cells.

"the patient-derived NSCs exhibited higher bromodeoxyuridine (BrdU) incorporation than the control NSCs"

The publication describes the donor as an ASD patient with a pathogenic POGZ variant; it does not establish that this single model captures the breadth of clinically diagnosed White-Sutton syndrome.

Show evidence (3 references)

PMID:32103003 SUPPORT In Vitro

"We established iPSC lines using immortalized B cells obtained from that patient and an unaffected healthy control (Supplementary Fig. 6) and differentiated each iPSC lines into NSCs."

Establishes the patient-derived and control iPSC-to-neural-stem-cell model.

PMID:32103003 SUPPORT In Vitro

"the radial migration of young neurons was significantly attenuated in the patient-derived NSCs"

Supports the migration component of the model phenotype.

PMID:32103003 SUPPORT In Vitro

"the patient-derived NSCs exhibited higher bromodeoxyuridine (BrdU) incorporation than the control NSCs"

Supports increased proliferation in patient-derived neural stem cells.

🐁

Animal Models

2

Heterozygous knock-in of a patient-derived de novo POGZ mutation Mouse

The first mouse model heterozygous for a de novo POGZ mutation identified in a patient ascertained for ASD. It shows ASD-like abnormalities and impaired mature cortical network function, and its social deficits are reversible by compensatory inhibition of elevated cell excitability. The model is informative for POGZ-associated neurodevelopmental disease but does not represent the full White-Sutton phenotype or allelic spectrum.

Species

Mouse

Genotype

Heterozygous knock-in of a patient-derived de novo POGZ mutation

Genes

POGZ hgnc:18801

Show evidence (1 reference)

PMID:32103003 SUPPORT Model Organism

"We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice."

Establishes construct and ASD-related face validity of the heterozygous knock-in mouse while retaining the publication's donor ascertainment.

Brain-specific conditional Pogz knockout Mouse

An independent brain-specific conditional knockout that reproduces microcephaly, growth impairment, and learning and motor deficits, and localises the dominant transcriptional and physiological consequence of Pogz loss to the cerebellum. Important caveat: this model shows INCREASED sociability, the opposite direction to the heterozygous knock-in model, so the two are not interchangeable for testing social-behaviour hypotheses.

Species

Mouse

Genotype

Brain-specific conditional Pogz knockout

Genes

POGZ hgnc:18801

Show evidence (2 references)

PMID:33203851 SUPPORT Model Organism

"Here, we generate a brain specific conditional knockout mouse model deficient for Pogz, an ASD risk gene."

Describes the second, independent mouse model of Pogz deficiency.

PMID:33203851 SUPPORT Model Organism

"Pogz deficient mice show microcephaly, growth impairment, increased sociability, learning and motor deficits, mimicking several of the human symptoms."

Face validity is partial - microcephaly, growth impairment and learning/motor deficits match the human phenotype, but the increased sociability does not and contradicts the other model.

{ }

Source YAML

click to show

name: White-Sutton Syndrome
creation_date: "2026-07-31T00:00:00Z"
description: >-
  White-Sutton syndrome (WHSUS;
  intellectual disability-microcephaly-strabismus-behavioral abnormalities
  syndrome; OMIM 616364) is an autosomal dominant
  neurodevelopmental disorder caused by heterozygous, usually de novo,
  pathogenic variants in POGZ (1q21.3), most of which are sequence-classified as
  loss of function. POGZ encodes pogo transposable element-derived protein with
  zinc finger domain, a multidomain chromatin-binding nuclear protein that acts in
  transcriptional regulation and neuronal development. The phenotype spans a wide cognitive range, from learning
  difficulties with a distinctive dysexecutive/attentional profile through to
  severe intellectual disability, and is accompanied by developmental delay that
  is disproportionately marked in speech and language, hypotonia, autism spectrum
  disorder and other behavioural problems. Commonly reported additional features
  are seizures, refractive errors and strabismus, hearing loss, sleep disturbance
  (particularly obstructive sleep apnoea), feeding and gastrointestinal problems,
  mild male genital abnormalities and urinary tract involvement. Increased body
  mass index, craniofacial dysmorphism (microcephaly, broad forehead, midface
  hypoplasia, flat nasal bridge, triangular mouth) and structural brain
  malformations are also documented. In one referral diagnostic laboratory, POGZ
  variants accounted for roughly 0.14% of clinical exomes performed for
  neurological indications; that figure is a diagnostic yield, not population
  prevalence.
category: Mendelian
parents:
- Neurodevelopmental Disorder
- Syndromic Intellectual Disability
notes: >-
  Scope and disambiguation. POGZ is one of the most recurrently de novo mutated
  genes in large autism and neurodevelopmental-disorder exome studies, so the
  literature contains a great deal of generic ASD/chromatin-gene material in which
  POGZ appears only as one entry in a candidate-gene list. This entry is anchored
  on White-Sutton syndrome as a clinical entity (MONDO:0014606 / OMIM 616364), and
  evidence was taken from WHSUS-specific cohorts, case series and the GeneReviews
  chapter rather than from generic autism gene-discovery papers. POGZ also has a
  separate, unrelated literature as a homology-directed DNA-repair factor and in
  cancer contexts; that work was excluded.
  Module conformance. No module in kb/modules/ captures a
  chromatin/transcription-regulator neurodevelopmental chain. The existing
  neurodevelopmental modules
  specify machinery (microtubule motors, Reelin, centrosome/spindle, interneuron
  fate) that the POGZ evidence does not implicate.
  `epilepsy_excitation_inhibition_imbalance` was evaluated more seriously, because
  the Pogz mouse work shows elevated cell excitability whose compensatory
  inhibition rescues social deficits; it was still declined, because that finding
  concerns social behaviour in a mouse rather than a curated
  seizure-generation/epileptogenesis chain in humans, and the human epilepsy here
  is a frequent comorbidity rather than a modelled E/I mechanism. The excitability
  finding is instead curated as its own node with MODEL_ORGANISM evidence.
disease_term:
  preferred_term: White-Sutton syndrome
  term:
    id: MONDO:0014606
    label: intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome
synonyms:
- WHSUS
- White-Sutton syndrome
- POGZ-related intellectual disability syndrome
- POGZ-related neurodevelopmental disorder
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  - classification_value: NEUROLOGIC
references:
- reference: PMID:34529370
  title: "White-Sutton Syndrome."
  tags:
  - GeneReviews
prevalence:
- population: Published individuals worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    Case counts rose from over 50 reported worldwide in 2019 to about 80 by 2023;
    a 2022 genotype-phenotype analysis pooled 117 individuals. No population
    prevalence estimate has been established.
  evidence:
  - reference: PMID:35052493
    reference_title: "Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Overall, 117 POGZ patients' genotype and phenotype data were included in the analysis, including 12 novel patients."
    explanation: Quantifies the pooled published caseload as of 2022, supporting an ultra-rare classification.
  - reference: PMID:37016333
    reference_title: "White-Sutton syndrome and congenital heart disease: case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "To date, 80 cases have been reported in the literature; however, the phenotypic characterizations remain incomplete."
    explanation: Independently reports the published caseload and notes that phenotypic characterisation is still incomplete.
inheritance:
- name: Autosomal dominant, typically de novo
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  expressivity: VARIABLE
  description: >-
    White-Sutton syndrome is autosomal dominant and in most cases arises from a de
    novo POGZ variant. Inheritance from a heterozygous parent who has
    developmental delay and/or mild intellectual disability is documented but
    rare, so parental testing is required before counselling recurrence risk.
    Expressivity is markedly variable even within families, spanning learning
    difficulties to severe intellectual disability.
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton syndrome is an autosomal dominant disorder typically caused by a de novo pathogenic variant. Most probands reported to date whose parents have undergone molecular genetic testing have the disorder as the result of a de novo POGZ pathogenic variant. Rarely, individuals with White-Sutton syndrome have the disorder as the result of a POGZ pathogenic variant inherited from a heterozygous parent with features such as developmental delay and/or mild intellectual disability."
    explanation: GeneReviews states the autosomal dominant, predominantly de novo mechanism and the rare inherited exception with a mildly affected transmitting parent.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we identified 12 individuals from 10 families with pathogenic or likely pathogenic variants in POGZ (eight de novo and two inherited)"
    explanation: Quantifies the de novo versus inherited split in a clinical series, documenting that familial transmission occurs.
pathophysiology:
- name: Pathogenic POGZ Variant Dysfunction
  biological_scale: MOLECULAR
  description: >-
    Heterozygous nonsense, frameshift and splice variants, and a minority of
    missense variants, in POGZ reduce or alter the function of a multidomain
    nuclear protein. The genotype-phenotype relationship is not a simple dosage
    gradient: missense variants are associated with milder phenotypes, while
    truncating variants predicted to ESCAPE nonsense-mediated decay produce the
    most severe phenotypes, and within that group variants in the proline-rich
    region are the most severe of all. The authors infer that a gain-of-function
    or dominant-negative effect from a stable truncated protein may contribute to
    the severe end of the spectrum, but this allelic mechanism has not been
    demonstrated experimentally.
  genes:
  - preferred_term: POGZ
    term:
      id: hgnc:18801
      label: POGZ
  molecular_functions:
  - preferred_term: chromatin binding
    term:
      id: GO:0003682
      label: chromatin binding
    modifier: ABNORMAL
  downstream:
  - target: Loss of POGZ-HP1 Heterochromatin Repression
    causal_link_type: DIRECT
    description: >-
      Altered POGZ function compromises the HP1-dependent repressive activity
      that POGZ exerts at pericentric heterochromatin.
  - target: Premature Cell-Cycle Exit in Cortical Progenitors
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Independently of its transcriptional-repressor role, POGZ is required for
      normal mitotic progression, so its loss reduces the number of dividing
      cortical progenitors. Curated as a separate arm from the transcriptional
      node because the reported intermediates are mitotic (kinetochore assembly
      and chromosome segregation) rather than transcriptional.
  - target: Disrupted POGZ-Dependent Transcriptional Regulation
    causal_link_type: DIRECT
    description: >-
      Altered POGZ function perturbs its transcriptional-regulatory role in the
      nucleus.
  evidence:
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton syndrome (WHSUS) is a neurodevelopmental disorder caused by heterozygous loss-of-function variants in POGZ."
    explanation: Establishes heterozygous POGZ loss-of-function variants as a major cause of the disorder, while the neutral node name also accommodates pathogenic missense alleles and unresolved effects of NMD-escaping truncations.
  - reference: PMID:35052493
    reference_title: "Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001). Within this group, variants in the prolin-rich region of the POGZ protein were associated with the most severe phenotypes (p = 0.0004)."
    explanation: Provides the quantitative genotype-phenotype correlation underlying the non-simple-dosage claim in this node.
  - reference: PMID:35052493
    reference_title: "Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ-associated neurodevelopmental disorders."
    explanation: The gain-of-function/dominant-negative interpretation is offered by the authors as a suggestion inferred from statistical association rather than demonstrated functionally, so it is curated as partial support.
- name: Loss of POGZ-HP1 Heterochromatin Repression
  biological_scale: MOLECULAR
  description: >-
    POGZ localises to pericentric heterochromatin in the same distribution as
    HP1-alpha and represses transcription in a dual-luciferase reporter assay.
    That repression is HP1-dependent: an H840A substitution in the HP1-binding
    zinc-finger-like (HPZ) domain, which abolishes the POGZ-HP1-alpha
    interaction, also abolishes repression. The HP1-binding step is therefore
    the molecular mechanism by which POGZ acts as a negative regulator of
    transcription, and is the specific activity lost in White-Sutton syndrome.
    The evidence is in vitro (HEK293 reporter assay, N2A immunofluorescence),
    so this node is curated at provisional confidence.
  mechanism_confidence: PROVISIONAL
  molecular_functions:
  - preferred_term: transcription corepressor activity
    term:
      id: GO:0003714
      label: transcription corepressor activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: heterochromatin formation
    term:
      id: GO:0031507
      label: heterochromatin formation
    modifier: ABNORMAL
  downstream:
  - target: Disrupted POGZ-Dependent Transcriptional Regulation
    causal_link_type: DIRECT
    description: >-
      Loss of the HP1-dependent repressive activity is the molecular basis for
      the transcriptional dysregulation - most conspicuously gene upregulation -
      seen when POGZ function is lost.
  evidence:
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "POGZ localizes to pericentric chromatin and represses transcription depending on HPZ."
    explanation: States the localisation and the HPZ dependence of repression that this node represents.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "To test if the interaction with HP1 is essential for transcription repression, we used POGZ with H840A mutation in the HPZ domain"
    explanation: Describes the HPZ-domain point mutation used to isolate the HP1-binding requirement.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "POGZ functions as a negative regulator of transcription depending on the interaction with HP1 proteins."
    explanation: The authors' conclusion that POGZ-mediated repression requires the HP1 interaction, which is the claim this node asserts.
- name: Disrupted POGZ-Dependent Transcriptional Regulation
  biological_scale: MOLECULAR
  description: >-
    POGZ is a multidomain nuclear protein that binds chromatin and participates in
    transcriptional regulation. Loss of normal POGZ function therefore perturbs
    the transcriptional programs it controls in the developing nervous system,
    which is the proximate step linking the genetic lesion to abnormal cortical
    development.
  biological_processes:
  - preferred_term: regulation of DNA-templated transcription
    term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
    modifier: ABNORMAL
  downstream:
  - target: Impaired Cortical Neuronal Development
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Perturbed transcriptional output in neural progenitors and developing
      neurons impairs cortical development.
  - target: Cerebellar Purkinje Cell Circuit Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Loss of POGZ's negative transcriptional regulation produces the largest gene
      upregulation in cerebellum, with a corresponding Purkinje cell defect.
  evidence:
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "POGZ (# 614787) encodes a multidomain nuclear protein involved in transcriptional regulation and its defective function has been recently associated with a syndromic neurodevelopmental disorder, known as White-Sutton syndrome (# 616364)."
    explanation: Establishes POGZ's identity as a multidomain nuclear transcriptional regulator and links defective function to White-Sutton syndrome, confirming the OMIM identity (616364) that matches the MONDO xref.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here, we show that POGZ regulates neuronal development and that ASD-related de novo mutations impair neuronal development in the developing mouse brain"
    explanation: Demonstrates in the developing mouse brain that POGZ regulates neuronal development and that disease-associated variants impair it.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "impair neuronal development in the developing mouse brain and induced pluripotent cell lines from an ASD patient"
    explanation: The same finding was reproduced in induced pluripotent cell lines from a patient, providing the human cellular arm; split from the mouse item so each carries a single evidence source.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "At the molecular level, luciferase reporter assay indicates that POGZ is a negative regulator of transcription. In accordance, in Pogz deficient mice we find a significant upregulation of gene expression, most notably in the cerebellum."
    explanation: Identifies the direction of POGZ's transcriptional role - it is a negative regulator, so loss of function causes gene upregulation, most markedly in cerebellum.
- name: Premature Cell-Cycle Exit in Cortical Progenitors
  biological_scale: CELLULAR
  description: >-
    In the embryonic (E15.5) cerebral cortex of Pogz-deficient mice the number
    of pHH3-positive mitotic cells is significantly reduced and the Tbr2-positive
    intermediate-progenitor layer is correspondingly expanded, while the
    Pax6-positive apical-progenitor layer is unchanged. The authors interpret
    this as accelerated exit from the cell cycle - a shift from symmetric
    proliferative to asymmetric differentiative division - which depletes the
    progenitor pool available to generate cortical neurons. The finding is
    mouse-only, so this node is curated at provisional confidence.
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  biological_processes:
  - preferred_term: cell proliferation in forebrain
    term:
      id: GO:0021846
      label: cell proliferation in forebrain
    modifier: DECREASED
  - preferred_term: mitotic cell cycle
    term:
      id: GO:0000278
      label: mitotic cell cycle
    modifier: ABNORMAL
  downstream:
  - target: Impaired Cortical Neuronal Development
    causal_link_type: DIRECT
    description: >-
      Early depletion of the cycling progenitor pool reduces the neurons
      available to build the cortex, which is the developmental lesion the
      downstream node represents.
  evidence:
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "we stained the sections for phospho-histone H3 (pHH3), which marks mitotic cells with condensed chromosomes"
    explanation: Identifies the mitotic marker used to quantify dividing progenitors in the embryonic cortex.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Our study shows that depletion of POGZ results in accelerated exit from the cell cycle in the developing cerebral cortex and a reduction in the number of cells in mitosis, which is consistent with the premature mitotic exit observed when POGZ was knockdown in human cells"
    explanation: States the reduced mitotic index and accelerated cell-cycle exit in the developing cortex that this node represents, and notes concordance with human-cell knockdown.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "POGZ was previously found to be essential for normal kinetochore assembly, mitotic chromosome segregation, and for normal mitotic progression"
    explanation: Provides the known mitotic function of POGZ that makes the reduced progenitor mitosis mechanistically interpretable.
- name: Impaired Cortical Neuronal Development
  biological_scale: CELLULAR
  description: >-
    Disease-associated de novo POGZ variants impair neuronal development in the
    developing mouse brain and in induced pluripotent cell lines derived from a
    patient. The consequence in the mature animal is impaired cortical network
    function, which is the cellular substrate proposed for the cognitive and
    behavioural phenotype.
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: cerebral cortex neuron
    term:
      id: CL:0010012
      label: cerebral cortex neuron
  biological_processes:
  - preferred_term: cerebral cortex neuron differentiation
    term:
      id: GO:0021895
      label: cerebral cortex neuron differentiation
    modifier: ABNORMAL
  downstream:
  - target: Elevated Neuronal Excitability
    causal_link_type: DIRECT
    description: >-
      Abnormal cortical development yields neurons with elevated intrinsic
      excitability.
  - target: Intellectual Disability
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Impaired cortical development underlies the cognitive impairment.
  - target: Structural Brain Malformation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The same developmental lesion produces the structural brain abnormalities
      documented on imaging.
  - target: Seizures
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Abnormal cortical development is the presumed substrate for the epilepsy;
      the intermediates are not established and no excitation/inhibition-imbalance
      claim is asserted.
  evidence:
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We established iPSC lines using immortalized B cells obtained from that patient and an unaffected healthy control (Supplementary Fig. 6) and differentiated each iPSC lines into NSCs."
    explanation: Establishes the patient-derived and control human iPSC neural-stem-cell system used to test the cellular developmental phenotype.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "the neuronal differentiation is impaired in patient-derived NSCs."
    explanation: Directly supports impaired neuronal differentiation in the patient-derived human neural model.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Our results provide insight into how de novo mutations on high-confidence ASD genes lead to impaired mature cortical network function, which underlies the cellular pathogenesis of NDDs, including ASD."
    explanation: States the impaired-mature-cortical-network outcome that this node represents.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice."
    explanation: Establishes the heterozygous knock-in mouse that reproduces disease-relevant behavioural abnormalities.
- name: Cerebellar Purkinje Cell Circuit Dysfunction
  biological_scale: CELLULAR
  description: >-
    A second, independent mouse model - brain-specific conditional Pogz knockout -
    localises the strongest transcriptional consequence of Pogz loss to the
    cerebellum and shows a corresponding physiological defect: reduced simple- and
    complex-spike firing frequency and increased inhibitory synaptic input
    amplitude in Purkinje cells. This model also reproduces microcephaly and
    growth impairment, matching the human phenotype. It is curated as a parallel
    arm to the cortical node rather than subsumed into it, because the two models
    implicate different circuits and, notably, report opposite social phenotypes.
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: Purkinje cell
    term:
      id: CL:0000121
      label: Purkinje cell
  downstream:
  - target: Microcephaly
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The same conditional-knockout model that shows the cerebellar defect also
      reproduces microcephaly and growth impairment.
  evidence:
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Physiologically, Pogz deficiency is associated with a reduction in the firing frequency of simple and complex spikes and an increase in amplitude of the inhibitory synaptic input in cerebellar Purkinje cells."
    explanation: Direct electrophysiological characterisation of the Purkinje cell defect in the conditional knockout.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We demonstrate that Pogz deficient mice show microcephaly, growth impairment, increased sociability, learning and motor deficits, mimicking several of the human symptoms."
    explanation: Establishes construct and partial face validity of this model, and records that it shows INCREASED sociability, the opposite direction to the other published Pogz mouse.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Our findings support a mechanism linking heterochromatin dysregulation to cerebellar circuit dysfunction and behavioral abnormalities in ASD."
    explanation: States the heterochromatin-to-cerebellar-circuit mechanism this node represents.
- name: Elevated Neuronal Excitability
  biological_scale: CELLULAR
  description: >-
    In the heterozygous Pogz mouse, social deficits can be treated by compensatory
    inhibition of elevated cell excitability, identifying raised neuronal
    excitability as a functionally causal and pharmacologically reversible node
    rather than a fixed developmental endpoint. This is the single most
    therapeutically interesting finding in the disorder and is the reason a
    reversibility discussion is recorded. It is currently mouse-only.
  mechanism_confidence: PROVISIONAL
  cell_types:
  - preferred_term: cerebral cortex neuron
    term:
      id: CL:0010012
      label: cerebral cortex neuron
  downstream:
  - target: Autistic Behavior
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Elevated excitability underlies the social deficits in the mouse model, the
      behavioural correlate of the human autistic phenotype.
  evidence:
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice."
    explanation: Demonstrates that elevated neuronal excitability is causal for the social phenotype in the mouse and that the deficit is pharmacologically reversible in that model.
phenotypes:
- category: Cognitive
  name: Intellectual Disability
  description: >-
    Cognitive impairment spans a wide range. In an unbiased national cohort of 19
    individuals, 14 had frank intellectual disability (6 mild, 5 moderate, 3
    severe) and the remaining 5 had learning disabilities with a shared
    neurocognitive profile of language difficulties, dysexecutive syndrome,
    attention disorders, slowness and social difficulties. Milder presentations
    are therefore likely to be under-ascertained.
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:33277917
    reference_title: "Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among the 19 patients, 14 patients exhibited ID (six mild, five moderate and three severe)."
    explanation: Quantifies frank intellectual disability at 14 of 19 (74%) in an unbiased national cohort, which falls in the FREQUENT (30-79%) band. The remaining 5 individuals had learning disabilities rather than intellectual disability, so the band is set on the HP:0001249 claim itself and not widened to cognitive impairment generally.
  - reference: PMID:33277917
    reference_title: "Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This study reveals that the cognitive phenotype of patients with POGZ pathogenic variants can range from learning disabilities to severe ID."
    explanation: Establishes the breadth of the cognitive range, which is why the entry does not assert a single severity level.
- category: Developmental
  name: Global Developmental Delay
  description: >-
    Developmental delay is near-universal and is disproportionately marked in
    speech and language acquisition.
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems."
    explanation: GeneReviews lists developmental delay among the defining features of the syndrome.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Most individuals had delayed development and/or intellectual disability."
    explanation: Confirms delayed development in most individuals of a 12-person series combined with 89 previously reported individuals.
- category: Neurological
  name: Speech and Language Delay
  description: >-
    Speech delay is the most consistently reported developmental feature and was
    present in every individual in one 22-person series.
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We observed a broad spectrum of intellectual disability and/or developmental delay with or without autism, and speech delay in all individuals."
    explanation: Speech delay was present in all 22 individuals of this series, supporting a VERY_FREQUENT band.
- category: Developmental
  name: Motor Delay
  description: >-
    Motor development is delayed in most affected individuals; one systematically
    phenotyped series reported some degree of motor delay in 19 of 22 people.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Motor delay
    term:
      id: HP:0001270
      label: Motor delay
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Some degree of motor delay was reported for 19/22 (86%) patients (delay was questionable in one additional case)."
    explanation: Quantifies motor delay at 86%, supporting the VERY_FREQUENT band.
- category: Neurological
  name: Hypotonia
  description: >-
    Hypotonia is a commonly reported feature and contributes to the early motor
    delay.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems"
    explanation: GeneReviews lists hypotonia among the characterising features; the unquantified listing maps to the FREQUENT band.
- category: Behavioral
  name: Autistic Behavior
  description: >-
    Autism spectrum disorder is a defining feature of the syndrome, though not all
    individuals meet criteria. Formal ascertainment is incomplete: in one
    systematically evaluated national cohort only a single patient underwent
    formal autism assessment.
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Autistic behavior
    term:
      id: HP:0000729
      label: Autistic behavior
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hypotonia, autism spectrum disorder, and other behavioral problems"
    explanation: GeneReviews lists autism spectrum disorder among the characterising features of the syndrome.
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We observed a broad spectrum of intellectual disability and/or developmental delay with or without autism"
    explanation: Explicitly notes that autism is present in some but not all individuals, which is why the band is FREQUENT rather than VERY_FREQUENT.
  - reference: PMID:33277917
    reference_title: "Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "One patient evaluated for autism was found to have moderate autism spectrum disorder."
    explanation: Documents that only one individual in this 19-person cohort underwent formal autism evaluation, sourcing the statement that formal ascertainment is incomplete.
- category: Behavioral
  name: Behavioral Problems
  description: >-
    Behavioural difficulties beyond autism are a consistent part of the phenotype.
    Aggressiveness and self-injury appear in the Orphanet-derived MONDO definition
    of the disorder; that is recorded here as background rather than cited as
    evidence, because no reference in this entry quantifies them.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Atypical behavior
    term:
      id: HP:0000708
      label: Atypical behavior
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "autism spectrum disorder, and other behavioral problems"
    explanation: GeneReviews lists other behavioural problems alongside autism among the characterising features.
  - reference: PMID:33277917
    reference_title: "Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton syndrome is a rare developmental disorder characterized by global developmental delay, intellectual disabilities (ID), and neurobehavioral abnormalities"
    explanation: Confirms neurobehavioural abnormalities as a defining component of the syndrome.
- category: Neurological
  name: Seizures
  description: >-
    Epilepsy is a recurrent feature that was not recognised in the original
    descriptions. Onset is mostly in infancy (1-4 years), with both focal and
    generalised seizures, EEG abnormalities predominantly in the frontal regions,
    and seizure control achievable with one or multiple antiseizure medications.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
    onset:
      onset_category: INFANTILE
      min_age_years: 1.0
      max_age_years: 4.0
      notes: >-
        Epilepsy onset is mostly during infancy, reported as 1-4 years of age in
        the POGZ-related epilepsy review (PMID:31136090).
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features commonly reported include seizures, refractive errors and strabismus, hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females."
    explanation: GeneReviews describes seizures as commonly reported, which maps to the FREQUENT band.
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "we detected that epilepsy onset is mostly during infancy (1-4 years of age), with both focal and generalized seizures. EEGs reveal that epileptic abnormalities mainly are localized in the frontal regions, and seizure control might be reached with one or multiple antiepileptic drugs."
    explanation: Characterises the electroclinical phenotype, onset window and treatability of POGZ-related epilepsy.
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "While originally epileptic seizures were unreported, it seems that epilepsy represents a recurrent feature in affected subjects."
    explanation: Documents that epilepsy was missed in the original phenotype descriptions and is now recognised as recurrent, which is a surveillance-relevant point.
- category: Neurological
  name: Microcephaly
  description: >-
    Microcephaly is part of the recognisable craniofacial pattern and is named in
    the MONDO/Orphanet description of the syndrome.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Common facial features included microcephaly, broad forehead, midface hypoplasia, triangular mouth, broad nasal root and flat nasal bridge."
    explanation: Microcephaly is listed among the common facial features of a 22-person series, supporting a FREQUENT band.
- category: Ophthalmological
  name: Strabismus
  description: >-
    Strabismus is a commonly reported ocular finding and one of the features named
    in the disorder's MONDO label.
  frequency: FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Additional features commonly reported include seizures, refractive errors and strabismus"
    explanation: GeneReviews lists strabismus among the commonly reported additional features.
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other common problems included ocular abnormalities, hearing loss and gait abnormalities."
    explanation: Confirms ocular abnormalities as a common problem in an independent series.
- category: Ophthalmological
  name: Refractive Error
  description: >-
    Refractive errors are commonly reported and require ophthalmological
    correction. Rod-cone dystrophy is described as a rare complication.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Abnormality of refraction
    term:
      id: HP:0000539
      label: Abnormality of refraction
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizures, refractive errors and strabismus, hearing loss"
    explanation: GeneReviews lists refractive errors among the commonly reported additional features.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The results demonstrate WHSUS is associated with variable developmental delay or intellectual disability, increased risk of obesity, visual defects, craniofacial dysmorphism, sensorineural hearing loss, feeding problems, seizures, and structural brain malformations."
    explanation: Confirms visual defects as an established association in a pooled analysis of 101 individuals.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our series includes further individuals with rod-cone dystrophy, cleft lip and palate, congenital diaphragmatic hernia, and duplicated renal drainage system, suggesting these are rare complications of WHSUS."
    explanation: Identifies rod-cone dystrophy explicitly as a rare complication, sourcing that claim in this phenotype's description.
- category: Auditory
  name: Sensorineural Hearing Loss
  description: >-
    Sensorineural hearing loss is an established association and requires
    audiological assessment.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "increased risk of obesity, visual defects, craniofacial dysmorphism, sensorineural hearing loss, feeding problems, seizures, and structural brain malformations"
    explanation: Sensorineural hearing loss is established in a pooled analysis of 101 individuals.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "refractive errors and strabismus, hearing loss, sleep disturbance"
    explanation: GeneReviews lists hearing loss among the commonly reported additional features.
- category: Behavioral
  name: Sleep Disturbance
  description: >-
    Sleep disturbance is common and is broader than obstructive sleep apnoea
    alone. A systematic screen of previously described individuals with causative
    POGZ variants found sleep disturbances in 52%, and obesity was not a risk
    factor for them, arguing that the sleep phenotype is intrinsic to the disorder
    rather than secondary to body habitus.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:38350721
    reference_title: "Exploring the molecular pathways linking sleep phenotypes and POGZ-associated neurodevelopmental disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sleep disturbances were observed in 52% of patients, and being obese was not observed as a risk factor for sleep problems."
    explanation: Quantifies sleep disturbance at 52% across previously described POGZ variant carriers, squarely in the FREQUENT (30-79%) band, and shows it is not driven by obesity.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems"
    explanation: GeneReviews lists sleep disturbance among the commonly reported additional features.
- category: Respiratory
  name: Obstructive Sleep Apnea
  description: >-
    Sleep disturbance, particularly obstructive sleep apnoea, is a commonly
    reported feature. A validated sleep-disordered-breathing questionnaire
    identified symptoms of obstructive sleep apnoea in 4 of 12 individuals
    screened, suggesting it is under-detected without active screening.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Obstructive sleep apnea
    term:
      id: HP:0002870
      label: Obstructive sleep apnea
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A validated sleep disordered breathing questionnaire identified symptoms of obstructive sleep apnea in 4/12 (33%) individuals."
    explanation: A questionnaire found obstructive-sleep-apnoea symptoms in 33%, but did not confirm all cases polysomnographically; it therefore only partially supports the phenotype-specific rate.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "hearing loss, sleep disturbance (particularly sleep apnea), feeding and gastrointestinal problems"
    explanation: GeneReviews identifies sleep apnoea specifically as the characteristic sleep disturbance.
- category: Gastrointestinal
  name: Gastrointestinal Involvement
  description: >-
    Gastrointestinal involvement is very common and heterogeneous. Specific
    feeding, swallowing, bowel and vomiting manifestations are represented
    separately below where the cohort provides phenotype-specific numerators.
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Abnormality of the gastrointestinal tract
    term:
      id: HP:0011024
      label: Abnormality of the gastrointestinal tract
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "GI involvement occurred in the majority (17/19, 89%) of the individuals for whom information was available."
    explanation: Quantifies any gastrointestinal involvement at 89%, supporting the VERY_FREQUENT band for the broad phenotype.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "feeding and gastrointestinal problems, mild genital abnormalities in males, and urinary tract involvement in both males and females"
    explanation: GeneReviews lists feeding and gastrointestinal problems among the commonly reported additional features.
- category: Gastrointestinal
  name: Feeding Difficulties
  description: >-
    Feeding difficulties were reported in a majority of one systematically
    surveyed cohort.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eleven (11/18, 61%) had a history of feeding difficulties."
    explanation: Quantifies feeding difficulties at 61%, supporting the FREQUENT band.
- category: Gastrointestinal
  name: Dysphagia
  description: Swallowing problems were reported in just over half of one systematically surveyed cohort.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Nine subjects (9/17, 53%) had dysphagia/swallowing problems"
    explanation: Quantifies dysphagia or swallowing problems at 53%, supporting the FREQUENT band.
- category: Gastrointestinal
  name: Constipation
  description: Constipation was reported in nearly half of individuals with gastrointestinal data in one cohort.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "eight (8/17, 47%) had constipation."
    explanation: Quantifies constipation at 47%, supporting the FREQUENT band.
- category: Gastrointestinal
  name: Episodic Vomiting
  description: >-
    Recurrent episodes described as cyclic vomiting are a notable component of
    the gastrointestinal phenotype.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Episodic vomiting
    term:
      id: HP:0002572
      label: Episodic vomiting
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Cyclic vomiting was reported in 6/16 (37.5%) of subjects"
    explanation: Quantifies recurrent cyclic vomiting at 37.5%, supporting the FREQUENT band and mapping it to the broader HP episodic-vomiting concept.
- category: Metabolic
  name: Increased Body Weight
  description: >-
    Overweight or obesity affected 6 of 16 individuals with available body-mass
    data in one cohort, and a pooled analysis independently identified increased
    obesity risk.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Increased body weight
    term:
      id: HP:0004324
      label: Increased body weight
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Overall, 6/16 (37.5%) were overweight or obese."
    explanation: Directly quantifies overweight or obesity at 37.5%, supporting the FREQUENT band without inferring a threshold frequency from a mean BMI z-score.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "increased risk of obesity"
    explanation: Independently confirms increased obesity risk in a pooled analysis.
- category: Genitourinary
  name: Genitourinary Anomalies
  description: >-
    Mild genital abnormalities in males and urinary tract involvement in both
    sexes are commonly reported, with genitourinary anomalies over-represented in
    systematically phenotyped series. No cohort reports a proportion for the
    combined genitourinary category, so the band is set conservatively.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Abnormality of the genitourinary system
    term:
      id: HP:0000119
      label: Abnormality of the genitourinary system
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "mild genital abnormalities in males, and urinary tract involvement in both males and females"
    explanation: GeneReviews lists genital and urinary tract involvement among the commonly reported additional features.
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "as well as genitourinary anomalies"
    explanation: Confirms genitourinary anomalies as over-represented in this series.
- category: Genitourinary
  name: Male Genital Abnormalities
  description: >-
    Mild abnormalities reported in affected males include undescended or
    hypoplastic testes, scrotal hypoplasia, micropenis and foreskin anomalies.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Abnormality of the male genitalia
    term:
      id: HP:0010461
      label: Abnormality of the male genitalia
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mild male genital anomalies were reported in four of 14 (28.6%) male subjects including undescended testes, hypoplastic scrotum, hypoplastic testes and micropenis, and redundant foreskin with phimosis."
    explanation: Quantifies the broad male-genital phenotype at 28.6%, supporting the OCCASIONAL band and enumerating its reported manifestations.
- category: Neurological
  name: Structural Brain Malformation
  description: >-
    Structural brain malformations are an established association. Reported MRI
    features include cortical and cerebellar atrophy, delayed myelination and
    brainstem hypoplasia.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Abnormal brain morphology
    term:
      id: HP:0012443
      label: Abnormal brain morphology
  evidence:
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizures, and structural brain malformations"
    explanation: Establishes structural brain malformations as an association in a pooled analysis; no numerator is given, so the band is set conservatively.
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "major brain MR features include cortical and cerebellar atrophy, delayed myelination, and brainstem hypoplasia"
    explanation: Enumerates the specific MRI abnormalities seen in the subset with epilepsy.
- category: Neurological
  name: Gait Abnormality
  description: >-
    Gait abnormalities are a common problem in systematically assessed series.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Gait disturbance
    term:
      id: HP:0001288
      label: Gait disturbance
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Other common problems included ocular abnormalities, hearing loss and gait abnormalities."
    explanation: Gait abnormalities are described as a common problem in a 22-person series, mapping to the FREQUENT band.
- category: Craniofacial
  name: Broad Forehead
  description: >-
    A broad forehead is part of the recognisable craniofacial pattern, which also
    includes midface hypoplasia, a triangular mouth and a broad nasal root with a
    flat nasal bridge.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Broad forehead
    term:
      id: HP:0000337
      label: Broad forehead
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Common facial features included microcephaly, broad forehead, midface hypoplasia, triangular mouth, broad nasal root and flat nasal bridge."
    explanation: A broad forehead is listed among the common facial features of this series.
- category: Craniofacial
  name: Midface Retrusion
  description: >-
    Midface hypoplasia is part of the recognisable craniofacial pattern.
  frequency: FREQUENT
  phenotype_term:
    preferred_term: Midface retrusion
    term:
      id: HP:0011800
      label: Midface retrusion
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "microcephaly, broad forehead, midface hypoplasia, triangular mouth"
    explanation: Midface hypoplasia is listed among the common facial features of this series.
- category: Cardiovascular
  name: Congenital Heart Disease
  description: >-
    Congenital heart disease, characteristically atrial septal defect, has been
    reported in a growing number of individuals. Its relationship to the syndrome
    was previously described as unclear in GeneReviews and OMIM; a 2023 review
    collected 18 prior cases and argued for a genuine association. This is
    curated as an emerging rather than established feature.
  frequency: OCCASIONAL
  phenotype_term:
    preferred_term: Congenital heart disease
    term:
      id: HP:0001627
      label: Abnormal heart morphology
  evidence:
  - reference: PMID:37016333
    reference_title: "White-Sutton syndrome and congenital heart disease: case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A review of the current literature revealed 18 cases of White-Sutton syndrome with POGZ variants and congenital heart disease, and we summarize their clinical features in this study."
    explanation: Quantifies 18 previously reported cases with congenital heart disease, which against a published caseload of about 80 is consistent with an OCCASIONAL band.
  - reference: PMID:37016333
    reference_title: "White-Sutton syndrome and congenital heart disease: case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The relationship between congenital heart disease and White-Sutton syndrome as described in both the GeneReview and OMIM databases (#616,364) remains unclear."
    explanation: Records that the association was not established in the authoritative databases at the time, which is why this phenotype is curated as emerging and the evidence as partial.
imaging_findings:
- name: Structural brain abnormalities on MRI
  modality: MRI
  imaging_finding_term:
    preferred_term: Abnormal brain morphology
    term:
      id: HP:0012443
      label: Abnormal brain morphology
  description: >-
    Reported MRI abnormalities include cortical and cerebellar atrophy, delayed
    myelination and brainstem hypoplasia. These findings are variable and
    supportive, not diagnostic.
  located_in:
    preferred_term: brain
    term:
      id: UBERON:0000955
      label: brain
  phenotype_term:
    preferred_term: Abnormal brain morphology
    term:
      id: HP:0012443
      label: Abnormal brain morphology
  diagnostic: false
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizures, and structural brain malformations"
    explanation: Establishes structural brain malformations as part of the reported clinical spectrum.
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "major brain MR features include cortical and cerebellar atrophy, delayed myelination, and brainstem hypoplasia"
    explanation: Enumerates the MRI appearances represented by this imaging finding.
genetic:
- name: POGZ
  gene_term:
    preferred_term: POGZ
    term:
      id: hgnc:18801
      label: POGZ
  association: Causal - heterozygous pathogenic variants
  relationship_type: CAUSATIVE
  presence: Positive
  notes: >-
    POGZ is at 1q21.3. Most pathogenic variants are heterozygous and de novo, and
    are nonsense, frameshift or splice alleles; missense variants also occur and
    are associated with milder phenotypes. The severity gradient does not follow a
    simple loss-of-function dosage model: truncating variants predicted to escape
    nonsense-mediated decay give the most severe phenotypes, and among those,
    variants in the proline-rich region are the most severe, suggesting a
    gain-of-function or dominant-negative contribution from a stable truncated
    protein. Familial transmission from a mildly affected heterozygous parent is
    documented, so both parents should be tested. Note that the two published Pogz
    mouse models disagree on the direction of the social phenotype; that is
    recorded in `discussions`.
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Here we report the clinical features of 22 individuals with 21 unique loss of function POGZ variants."
    explanation: Documents the loss-of-function variant spectrum across a 22-person series with near-unique variants.
  - reference: PMID:35052493
    reference_title: "Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001)."
    explanation: Establishes the statistically supported genotype-severity relationship, including the NMD-escape effect.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our work further delineates the phenotypic spectrum of WHSUS highlighting the variable severity of this disorder and the observation of familial pathogenic POGZ variants."
    explanation: Documents both the variable severity and the occurrence of familial (inherited) pathogenic POGZ variants.
diagnosis:
- name: Molecular Genetic Testing for POGZ
  description: >-
    The diagnosis is established by identifying a heterozygous pathogenic POGZ
    variant in an individual with suggestive findings, typically on exome or
    genome sequencing or a neurodevelopmental gene panel. Because the cognitive
    phenotype extends down to learning difficulties, the authors of the French
    cohort argue that children with learning disabilities may benefit from
    next-generation sequencing rather than being excluded from testing. In one
    diagnostic laboratory, POGZ variants accounted for approximately 0.14% of
    clinical exomes referred for neurological indications; this is a referral
    yield, not a population prevalence estimate.
  presence: Positive in affected individuals
  diagnosis_term:
    preferred_term: molecular genetic testing
    term:
      id: NCIT:C19770
      label: Molecular Analysis
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The diagnosis of White-Sutton syndrome is established in a proband with suggestive findings and a heterozygous pathogenic variant in POGZ identified by molecular genetic testing."
    explanation: GeneReviews states the molecular diagnostic criterion.
  - reference: PMID:33277917
    reference_title: "Neuropsychological study in 19 French patients with White-Sutton syndrome and POGZ mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It highlights that pathogenic variations in the same genes can be reported in a large spectrum of neurocognitive profiles, and that children with learning disabilities could benefit from next generation sequencing techniques."
    explanation: Supports extending genomic testing to milder learning-disability presentations, which is a direct diagnostic-strategy implication of the phenotypic range.
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Analysis of the Baylor Genetics clinical laboratory database revealed that POGZ variants were implicated in approximately 0.14% of cases who underwent clinical exome sequencing for neurological indications with or without involvement of other body systems."
    explanation: Records the diagnosis yield in an ascertained referral laboratory while explicitly keeping it separate from population occurrence.
- name: Sleep-Disordered-Breathing Assessment
  description: >-
    Sleep symptoms should be assessed as part of routine specialist follow-up.
    In one small cohort, a validated sleep-disordered-breathing questionnaire
    identified obstructive-sleep-apnoea symptoms in 4 of 12 individuals; this
    establishes a screening observation, not the accuracy of a diagnostic test or
    a syndrome-specific treatment protocol.
  results: Questionnaire symptoms of obstructive sleep apnea were identified in 4 of 12 individuals screened.
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A validated sleep disordered breathing questionnaire identified symptoms of obstructive sleep apnea in 4/12 (33%) individuals."
    explanation: Documents questionnaire-based detection of obstructive-sleep-apnoea symptoms while not claiming polysomnographic confirmation or management efficacy.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Surveillance: Follow up of the common manifestations at each clinic visit."
    explanation: Supports routine follow-up of common manifestations, including the sleep disturbance identified elsewhere in the same GeneReviews abstract, but does not prescribe a sleep-specific protocol.
differential_diagnoses:
- name: Other Syndromic Intellectual Disability with Autism
  description: >-
    White-Sutton syndrome has no pathognomonic feature; the combination of
    speech-predominant developmental delay, autism, hypotonia, ocular findings and
    increased BMI is suggestive but the diagnosis is molecular. Broad genomic
    testing rather than targeted single-gene testing is the practical approach.
  evidence:
  - reference: PMID:38019139
    reference_title: "Discriminative features in White-Sutton syndrome: literature review and first report in Iran."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton Syndrome is one of the rare neurodevelopmental disorder inherited in an autosomal dominant manner, mainly caused by de novo mutations in the POGZ gene and shows many phenotypic signs such as intellectual disability, Autism Spectrum Disorder and other spectra."
    explanation: A literature review specifically framed around discriminative features concludes the presentation is a nonspecific intellectual-disability/autism spectrum, which is why the differential is broad and the diagnosis molecular.
  - reference: PMID:38019139
    reference_title: "Discriminative features in White-Sutton syndrome: literature review and first report in Iran."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The results of Whole Exome Sequencing test, performed for the patient, declared the presence of a de novo mutation in POGZ gene and confirmed the White-Sutton Syndrome diagnosis."
    explanation: Illustrates the practical point that broad sequencing rather than clinical discrimination establishes the diagnosis.
- name: Nonsyndromic Autism Spectrum Disorder
  description: >-
    POGZ is one of the most recurrently de novo mutated genes in autism cohorts,
    so individuals may first be labelled with idiopathic ASD; the associated
    dysmorphism, ocular, auditory, gastrointestinal and genitourinary findings
    should prompt genomic testing.
- name: Helsmoortel-Van der Aa Syndrome (ADNP)
  disease_term:
    preferred_term: ADNP-related syndrome
    term:
      id: MONDO:0014379
      label: ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
  description: >-
    The most mechanistically apposite differential. ADNP, like POGZ, is a
    high-confidence de novo autism gene whose product participates in
    HP1-binding chromatin complexes, and the two disorders converge clinically
    on speech-predominant developmental delay, autism, hypotonia, feeding
    difficulty, visual problems and a recognisable but non-specific facial
    gestalt. The disorders are separated by molecular testing, not by phenotype.
  distinguishing_features:
  - The causative gene - ADNP versus POGZ - identified by exome or genome sequencing is the only reliable discriminator; the two are not separable on clinical grounds.
  evidence:
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "heterochromatin formation, or participate in complexes that bind different isotypes of the human heterochromatin protein 1 (HP1) (e.g. SUV420H113, ADNP14 and POGZ15–19)."
    explanation: The paper explicitly names ADNP and POGZ among high-confidence ASD-risk genes linked to HP1-binding chromatin biology, supporting mechanistic proximity while not establishing clinical indistinguishability.
- name: Other Chromatinopathy-Associated Neurodevelopmental Disorders
  description: >-
    CHAMP1, CHD8, KBG syndrome (ANKRD11), Coffin-Siris syndrome (BAF complex)
    and Wiedemann-Steiner syndrome (KMT2A) all produce syndromic intellectual
    disability with autism through lesions in chromatin regulators and overlap
    substantially with White-Sutton syndrome. They are listed as a group because
    none is separable from POGZ-related disease on clinical grounds; exome or
    genome sequencing is the discriminator.
- name: Smith-Magenis Syndrome (RAI1)
  description: >-
    Shares intellectual disability, behavioural problems including self-injury,
    sleep disturbance and obesity; distinguished by molecular testing.
- name: Prader-Willi Syndrome
  description: >-
    Shares hypotonia, developmental delay, behavioural difficulties and obesity;
    distinguished by methylation testing of the 15q11-q13 region.
progression:
- phase: Neurodevelopmental presentation and clinical recognition
  age_range: First evaluation from one week to 28 years in one reported cohort
  notes: >-
    The disorder is developmental, but age at recognition is broad and diagnostic
    delay can be prolonged. One cohort reported first medical evaluation from the
    neonatal period to adulthood and a delay from first concern to molecular
    diagnosis of more than 15 years in some individuals. Published cohorts do not
    yet define adult longitudinal progression, mortality or life expectancy.
  evidence:
  - reference: PMID:31782611
    reference_title: "Phenotypic expansion of POGZ-related intellectual disability syndrome (White-Sutton syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Ages at first medical evaluation ranged from one week (presenting with birth defects) to 28 years (subject seen for calcinosis cutis, and noted to have mild intellectual disability and polydactyly). Median age at diagnosis was eight years, and the time from initial concern to diagnosis ranged from two months to over 15 years."
    explanation: Directly supports the broad recognition range and prolonged diagnostic delay; it does not establish the natural history of manifestations in adulthood.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "White-Sutton syndrome is a neurodevelopmental disorder characterized by a wide spectrum of cognitive dysfunction, developmental delays (particularly in speech and language acquisition), hypotonia, autism spectrum disorder, and other behavioral problems."
    explanation: Establishes the developmental nature of the presentation but does not provide longitudinal adult-course data.
treatments:
- name: Multidisciplinary Standard-of-Care Management
  description: >-
    There is no disease-modifying therapy. Developmental delay and intellectual
    disability, speech and language acquisition, behavioural issues, seizures,
    refractive errors and strabismus, hearing impairment, sleep disturbance,
    feeding and gastrointestinal issues, and genitourinary problems are each
    managed by the relevant specialists per standard care, with follow-up of the
    common manifestations at every clinic visit.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Developmental delay/intellectual disability, speech and language acquisition, behavioral issues, seizures, refractive errors and strabismus, hearing impairment, sleep disturbance, feeding and gastrointestinal issues, and genitourinary problems are managed by specialists per standard care."
    explanation: GeneReviews defines the standard of care as specialist-led symptomatic management across the affected systems.
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Surveillance: Follow up of the common manifestations at each clinic visit."
    explanation: States the recommended surveillance regimen.
- name: Speech and Language Specialist Care
  description: >-
    Speech and language acquisition is the developmental domain most consistently
    affected. GeneReviews places it within specialist standard care, but the
    available review does not define a syndrome-specific therapy protocol or
    quantify treatment response.
  treatment_term:
    preferred_term: speech and language therapy
    term:
      id: NCIT:C159273
      label: Speech Language Therapy
  therapeutic_modality: BEHAVIORAL
  target_phenotypes:
  - preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "speech and language acquisition, behavioral issues, seizures"
    explanation: GeneReviews supports specialist management of speech and language acquisition, but the excerpt does not evaluate a specific speech-language therapy protocol or outcome.
- name: Antiseizure Medication
  description: >-
    Epilepsy is managed with standard antiseizure medication. A disorder-focused
    review reports that seizure control may be reached with one or multiple
    agents, without establishing comparative efficacy for any regimen.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  therapeutic_modality: SMALL_MOLECULE
  target_phenotypes:
  - preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:31136090
    reference_title: "POGZ-related epilepsy: Case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizure control might be reached with one or multiple antiepileptic drugs"
    explanation: Reports that seizure control may be achieved with one or multiple antiseizure medications, without comparing regimens.
- name: Genetic Counseling
  description: >-
    Counselling covers the autosomal dominant, predominantly de novo mechanism,
    the documented but rare inheritance from a mildly affected parent (so both
    parents should be tested before recurrence risk is quoted as low), and the
    availability of prenatal and preimplantation genetic testing once the familial
    variant is known.
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  therapeutic_modality: BEHAVIORAL
  evidence:
  - reference: PMID:34529370
    reference_title: "White-Sutton Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Once the POGZ pathogenic variant has been identified in an affected family member, prenatal and preimplantation genetic testing are possible."
    explanation: GeneReviews states the reproductive testing options that counselling addresses.
clinical_trials:
- name: NCT07380594
  status: RECRUITING
  description: >-
    PSY-POGZ (CHU Dijon Bourgogne), an observational descriptive study of
    psychiatric symptoms in White-Sutton syndrome. It is not an interventional
    trial - no disease-modifying therapy exists - but it is the only registered
    study specific to the disorder and targets the anxiety/behavioural
    dimension that is under-characterised relative to the developmental
    phenotype.
  target_phenotypes:
  - preferred_term: Anxiety
    term:
      id: HP:0000739
      label: Anxiety
  - preferred_term: Autistic behavior
    term:
      id: HP:0000729
      label: Autistic behavior
  - preferred_term: Attention deficit hyperactivity disorder
    term:
      id: HP:0007018
      label: Attention deficit hyperactivity disorder
  evidence:
  - reference: clinicaltrials:NCT07380594
    reference_title: "Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Psychiatrically, anxiety seems to predominate and manifest itself broadly in the form of generalised anxiety disorder, phobic disorder or obsessive-compulsive disorder. Some patients may also present with autism spectrum disorders, behavioural disorders and attention disorders with or without hyperactivity."
    explanation: States the psychiatric phenotype the study is designed to characterise.
  - reference: clinicaltrials:NCT07380594
    reference_title: "Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It is therefore essential to define more precisely the psychological characteristics of patients and the psychiatric comorbidities that may be associated with this condition in order to adapt behavioural, environmental and therapeutic management strategies."
    explanation: States the study objective, which is descriptive characterisation rather than intervention.
experimental_models:
- name: Q1042R POGZ patient-derived iPSC neural model
  experimental_model_type: IPSC_DERIVED_MODEL
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: neural progenitor cell
    term:
      id: CL:0011020
      label: neural progenitor cell
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  cell_source: >-
    Immortalized B cells from a person with sporadic ASD and de novo POGZ
    p.Gln1042Arg, and from an unaffected control, reprogrammed to iPSCs
  culture_system: iPSC differentiation to neural stem cells, followed by early neuronal differentiation and radial-migration assays
  conditions:
  - patient-derived POGZ p.Gln1042Arg cells
  - unaffected control-derived cells
  publication: PMID:32103003
  description: >-
    Patient-derived neural stem cells carrying POGZ p.Gln1042Arg showed reduced
    early neuronal differentiation, increased proliferation and attenuated
    radial migration relative to control cells. The donor was ascertained for
    sporadic ASD rather than as part of a White-Sutton syndrome cohort, so this
    is an informative human POGZ-neurodevelopmental-disorder model rather than a
    representative model of the full syndrome or its allelic spectrum.
  modeled_mechanisms:
  - target: Impaired Cortical Neuronal Development
    description: Models impaired neuronal differentiation and migration in human patient-derived neural cells.
    evidence:
    - reference: PMID:32103003
      reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: "The proportion of MAP2+ neurons was significantly lower in the patient-derived NSCs than in the control NSCs, suggesting that neuronal differentiation is impaired in the patient-derived NSCs"
      explanation: Directly links the patient-derived neural model to impaired neuronal differentiation.
  findings:
  - statement: Patient-derived neural stem cells showed impaired early neuronal differentiation.
    supporting_text: "the neuronal differentiation is impaired in patient-derived NSCs"
  - statement: Radial migration of young patient-derived neurons was attenuated.
    supporting_text: "the radial migration of young neurons was significantly attenuated in the patient-derived NSCs"
  - statement: Patient-derived neural stem cells showed increased proliferation relative to control cells.
    supporting_text: "the patient-derived NSCs exhibited higher bromodeoxyuridine (BrdU) incorporation than the control NSCs"
  evidence:
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "We established iPSC lines using immortalized B cells obtained from that patient and an unaffected healthy control (Supplementary Fig. 6) and differentiated each iPSC lines into NSCs."
    explanation: Establishes the patient-derived and control iPSC-to-neural-stem-cell model.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "the radial migration of young neurons was significantly attenuated in the patient-derived NSCs"
    explanation: Supports the migration component of the model phenotype.
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "the patient-derived NSCs exhibited higher bromodeoxyuridine (BrdU) incorporation than the control NSCs"
    explanation: Supports increased proliferation in patient-derived neural stem cells.
  notes: >-
    The publication describes the donor as an ASD patient with a pathogenic POGZ
    variant; it does not establish that this single model captures the breadth of
    clinically diagnosed White-Sutton syndrome.
animal_models:
- species: Mouse
  genotype: Heterozygous knock-in of a patient-derived de novo POGZ mutation
  genes:
  - preferred_term: POGZ
    term:
      id: hgnc:18801
      label: POGZ
  associated_phenotypes:
  - Autistic behavior
  - Impaired cortical development
  description: >-
    The first mouse model heterozygous for a de novo POGZ mutation identified in a
    patient ascertained for ASD. It shows ASD-like abnormalities and impaired
    mature cortical network function, and its social deficits are reversible by
    compensatory inhibition of elevated cell excitability. The model is
    informative for POGZ-associated neurodevelopmental disease but does not
    represent the full White-Sutton phenotype or allelic spectrum.
  evidence:
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice."
    explanation: Establishes construct and ASD-related face validity of the heterozygous knock-in mouse while retaining the publication's donor ascertainment.
- species: Mouse
  genotype: Brain-specific conditional Pogz knockout
  genes:
  - preferred_term: POGZ
    term:
      id: hgnc:18801
      label: POGZ
  associated_phenotypes:
  - Microcephaly
  - Growth impairment
  - Learning and motor deficits
  description: >-
    An independent brain-specific conditional knockout that reproduces
    microcephaly, growth impairment, and learning and motor deficits, and
    localises the dominant transcriptional and physiological consequence of Pogz
    loss to the cerebellum. Important caveat: this model shows INCREASED
    sociability, the opposite direction to the heterozygous knock-in model, so the
    two are not interchangeable for testing social-behaviour hypotheses.
  evidence:
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Here, we generate a brain specific conditional knockout mouse model deficient for Pogz, an ASD risk gene."
    explanation: Describes the second, independent mouse model of Pogz deficiency.
  - reference: PMID:33203851
    reference_title: "Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Pogz deficient mice show microcephaly, growth impairment, increased sociability, learning and motor deficits, mimicking several of the human symptoms."
    explanation: Face validity is partial - microcephaly, growth impairment and learning/motor deficits match the human phenotype, but the increased sociability does not and contradicts the other model.
discussions:
- discussion_id: whsus_allelic_mechanism
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Do pathogenic POGZ alleles act uniformly through haploinsufficiency, or do
    stable NMD-escaping truncations produce additional dominant-negative or
    gain-of-function effects that explain their greater clinical severity?
  attaches_to:
  - pathophysiology#Pathogenic POGZ Variant Dysfunction
  rationale: >-
    Heterozygous loss-of-function variants establish reduced POGZ activity as a
    major disease mechanism, but the strongest genotype-phenotype study found
    greater severity for truncations predicted to escape NMD and explicitly
    proposed dominant-negative or gain-of-function effects. That proposal is an
    inference from variant position and clinical severity, not a direct
    demonstration of mutant-transcript stability, truncated-protein abundance or
    altered chromatin occupancy. Resolving the allelic mechanism is important for
    interpreting genotype-severity associations and for deciding whether simple
    restoration of POGZ dosage would address all pathogenic allele classes.
  proposed_experiments:
  - experiment_id: whsus_isogenic_allelic_mechanism
    name: Isogenic comparison of NMD-triggering and NMD-escaping POGZ alleles
    description: >-
      Introduce representative NMD-triggering and NMD-escaping truncations into
      the same human iPSC background, differentiate them into neural progenitors
      and neurons, and compare allele-specific RNA, mutant-protein abundance,
      nuclear localisation, POGZ/HP1 chromatin occupancy, transcriptional output,
      neuronal differentiation and migration. Include correction of patient
      alleles and selective knockdown of the mutant transcript.
    decision_criterion: >-
      Phenotypes proportional to total functional POGZ dosage and rescued by
      wild-type restoration would support haploinsufficiency; effects unique to
      NMD-escaping alleles that improve after mutant-selective knockdown would
      support an additional dominant-negative or gain-of-function mechanism.
  evidence:
  - reference: PMID:35052493
    reference_title: "Genotype-Phenotype Comparison in POGZ-Related Neurodevelopmental Disorders by Using Clinical Scoring."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Our study suggests that gain-of-function or dominant negative effect through escaping NMD and the location of the variants in the prolin-rich domain of the protein may play an important role in the severity of manifestations of POGZ-associated neurodevelopmental disorders."
    explanation: The authors explicitly frame the alternative allelic mechanism as a suggestion, identifying a material unresolved causal question rather than a demonstrated mechanism.
- discussion_id: whsus_excitability_reversibility
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Does the reversibility of social deficits by compensatory inhibition of
    elevated neuronal excitability in the Pogz mouse translate to any tractable
    intervention in humans with White-Sutton syndrome?
  attaches_to:
  - pathophysiology#Elevated Neuronal Excitability
  rationale: >-
    The mouse result is unusual and important: it shows that at least one
    behavioural consequence of a developmental chromatin-regulator lesion is not
    fixed at birth but depends on an ongoing, pharmacologically addressable
    circuit state. If that held in humans it would change the therapeutic framing
    of the disorder from purely supportive to potentially modifiable. But there
    are no human data at all - no measurement of cortical excitability in
    individuals with POGZ variants, and no trial of any excitability-reducing
    agent for the social or cognitive phenotype. The mismatch is mechanistically
    meaningful because the human phenotype includes established structural brain
    malformations that the excitability model does not address, so even a true
    excitability contribution would explain only part of the picture. It is
    further complicated by direct disagreement between the two published Pogz
    mouse models: the knock-in model shows social DEFICITS rescued by inhibiting
    excitability, whereas the brain-specific conditional knockout reports
    INCREASED sociability alongside a cerebellar Purkinje cell defect. Any
    translational claim must account for that contradiction rather than
    generalising from one model.
  proposed_experiments:
  - experiment_id: whsus_human_excitability_measurement
    name: Cortical excitability measurement in POGZ variant carriers
    description: >-
      Use transcranial magnetic stimulation measures of cortical excitability
      and quantitative EEG in individuals with pathogenic POGZ variants versus
      matched neurodevelopmental controls.
    decision_criterion: >-
      Demonstrating elevated cortical excitability in humans would justify a
      trial of an excitability-reducing agent; normal excitability would confine
      the mouse finding to that model.
  - experiment_id: whsus_patient_ipsc_excitability
    name: Excitability phenotyping and rescue in patient-derived neurons
    description: >-
      Extend the existing patient iPSC work to mature cortical neurons and test
      whether elevated excitability is present and whether the same compensatory
      inhibition used in the mouse normalises network activity.
    decision_criterion: >-
      Reproduction and rescue in human neurons would bridge the model-to-human
      gap without requiring a clinical trial first.
  evidence:
  - reference: PMID:32103003
    reference_title: "Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice."
    explanation: The finding whose human translation is the open question; it is mouse-only.
  - reference: PMID:34645992
    reference_title: "Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "seizures, and structural brain malformations"
    explanation: The human phenotype includes structural brain malformations, which an excitability-only model does not account for, so the mismatch is not merely one of missing data.

📚

References & Deep Research

References

1

PMID:34529370

White-Sutton Syndrome.

No top-level findings curated for this source.

Deep Research

1

Falcon ▸

White-Sutton Syndrome: Disease Characteristics Research Report

Edison Scientific Literature 20 citations 2026-07-31T18:14:56.493214

White-Sutton Syndrome: Disease Characteristics Research Report

Executive summary

White-Sutton syndrome (WHSUS) is a rare, congenital neurodevelopmental chromatin disorder caused by a heterozygous pathogenic variant in POGZ. It is usually sporadic because the causal variant arises de novo, although mildly affected parents and familial transmission have been documented. Developmental and speech delay, variable intellectual disability, hypotonia, behavioral or autism-spectrum manifestations, characteristic but subtle craniofacial findings, visual abnormalities, feeding and gastrointestinal problems, sleep disturbance, hearing loss, seizures, and a tendency toward overweight are the principal manifestations. Severity is highly variable, including within families. There is no disease-modifying treatment; diagnosis is molecular and management is individualized, multidisciplinary, and symptom directed. The most informative large analyses through 2024 remain the 2020 cohort of 22 people, the 2022 clinical synthesis of 101 people, and the 2022 genotype–phenotype analysis of 117 people. Disease-specific publications in 2023–2024 were predominantly case reports and mechanistic/model work rather than new large natural-history cohorts.

The following table provides a compact knowledge-base extraction; the narrative below supplies interpretation and additional ontology recommendations.

Domain	Established findings	Evidence gaps / caveats	Suggested ontology terms	Key citations
Identifiers / synonyms	White-Sutton syndrome (WHSUS) is a rare neurodevelopmental disorder caused by heterozygous pathogenic variants in POGZ; OMIM 616364. Related MONDO label reported as intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome; Open Targets also maps disease as white-sutton syndrome. Synonyms in the literature include POGZ-related intellectual disability syndrome and POGZ-related neurodevelopmental disorder. Disease-level information here is derived from aggregated published cohorts and curated disease resources, not EHR-only data.	MONDO/EFO mapping is resource-dependent in the gathered evidence; no single ICD-10/ICD-11 code was identified in the retrieved sources.	MONDO: MONDO_0014606; MeSH/ICD not established from gathered evidence	(batzir2020phenotypicexpansionof pages 1-2, OpenTargets Search: White-Sutton syndrome-POGZ, murch2022furtherdelineationof pages 1-2)
Causal gene / inheritance	Causal gene: POGZ (pogo transposable element derived with ZNF domain; Ensembl ENSG00000143442). Inheritance is autosomal dominant / monoallelic, most often de novo. In the 22-person cohort, 18/21 informative variants were de novo, 1 maternally inherited, 2 unknown; in the 117-patient aggregate, ~90% were de novo and ~10% inherited.	Penetrance is not well quantified; inherited cases show variable expressivity. Modifier genes are not established from the gathered evidence.	Gene: POGZ; inheritance: autosomal dominant inheritance (HP:0000006)	(batzir2020phenotypicexpansionof pages 3-5, OpenTargets Search: White-Sutton syndrome-POGZ, nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 1-2)
Variant spectrum	Predominantly loss-of-function variants: nonsense, frameshift, splice-site, larger deletions; missense variants are less common. In the 117-patient analysis: nonsense 41%, frameshift 40%, missense 8.5%, splice-site 7%, larger deletions 2.5%, in-frame deletions 1%. Variants often cluster in exon 19 / domains including proline-rich region, CENP-B DNA-binding and DDE transposase-related regions. Truncating variants predicted to escape nonsense-mediated decay (NMD) were associated with more severe phenotypes; missense and NMD-subjected variants tended to be milder.	Population allele frequencies (e.g., gnomAD counts) were not retrieved here. Functional classification of each specific variant remains case-dependent. Somatic disease role not supported; this is a germline disorder.	Sequence ontology suggestions: stop_gained, frameshift_variant, splice_donor_variant, splice_acceptor_variant, copy_number_loss	(batzir2020phenotypicexpansionof pages 12-13, batzir2020phenotypicexpansionof pages 3-5, nagy2022genotypephenotypecomparisonin pages 9-10, nagy2022genotypephenotypecomparisonin pages 1-2, murch2022furtherdelineationof pages 1-2)
Core phenotype frequencies	Across the 22-person cohort: speech delay 100%, learning difficulties 100%, motor delay 86%, intellectual disability 87%, autism 37.5%; ocular abnormalities, hearing loss, gait abnormalities, GI and GU anomalies were common. Sleep-disordered breathing symptoms suggestive of OSA occurred in 4/12 (33%) tested. In the 117-patient aggregate, commonly reported features included facial dysmorphism 96%, speech delay 88%, global developmental delay 88%, ID 79%, behavioral abnormalities 75%, sleep disturbances 75%, ocular anomalies 63%, hypotonia 54%, sensorineural hearing impairment 54%, microcephaly 46%, seizures 60% (noting ascertainment/reporting variability). In the 12-person series, microcephaly was 8/12, early feeding problems 7/11, obesity 4/5 among those >10 years.	Frequencies vary substantially across cohorts because of incomplete reporting, ascertainment bias, and different denominators. Some features such as subtle genital anomalies and brachydactyly are likely underreported.	HPO suggestions: Global developmental delay (HP:0001263), Speech delay (HP:0000750), Intellectual disability (HP:0001249), Autism (HP:0000717), Hypotonia (HP:0001252), Microcephaly (HP:0000252), Sensorineural hearing impairment (HP:0000407), Abnormality of gait (HP:0001288), Obesity/Overweight (HP:0001513/HP:0025385), Obstructive sleep apnea (HP:0002870)	(batzir2020phenotypicexpansionof pages 11-12, batzir2020phenotypicexpansionof pages 1-2, batzir2020phenotypicexpansionof pages 7-8, batzir2020phenotypicexpansionof pages 8-9, nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 5-6, murch2022furtherdelineationof pages 1-2)
Mechanism / pathophysiology	Human genetics + model evidence support POGZ as a chromatin regulator interacting with HP1α, involved in chromosome segregation, mitotic progression, and transcriptional repression/organization. Mouse nervous-system knockout data show transcriptional upregulation, especially in cerebellum, enrichment of dysregulated genes in neurogenesis and synaptic processes, reduced mitotic cells in embryonic cortex, smaller brain, and Purkinje-cell electrophysiologic abnormalities (reduced simple/complex spike firing, increased inhibitory input amplitude). A plausible causal chain is: POGZ haploinsufficiency or abnormal truncated protein effect -> heterochromatin/transcription dysregulation and altered neuronal developmental programs -> abnormal circuit development/function, especially cerebellar pathways -> developmental delay, ID, motor and behavioral phenotypes.	Direct human tissue mechanistic studies remain limited. No disease-specific transcriptomic/proteomic biomarker is established from the retrieved human studies. Epigenetic episignature evidence for WHSUS was not retrieved.	GO suggestions: chromatin organization, negative regulation of transcription, mitotic chromosome segregation, neurogenesis, synaptic signaling; CL suggestions: Purkinje cell, cortical intermediate progenitor cell	(batzir2020phenotypicexpansionof pages 2-3, sulimanlavie2020pogzdeficiencyleads pages 1-2, sulimanlavie2020pogzdeficiencyleads pages 2-3, nagy2022genotypephenotypecomparisonin pages 1-2)
Diagnostic approach	Diagnosis in published cohorts was usually made by trio whole-exome sequencing, whole-genome sequencing, or intellectual-disability / neurodevelopmental gene panels; some patients also had chromosomal microarray without an alternative diagnosis. Because the clinical phenotype is relatively nonspecific and variable, genomic testing is the main diagnostic route. In Baylor clinical exome data, POGZ variants were implicated in about 0.14% of cases referred for neurodevelopmental indications.	No universally accepted clinical diagnostic criteria independent of molecular confirmation were identified. No validated biochemical biomarker, imaging signature, or episignature was retrieved from the gathered evidence.	NCIT/testing suggestions: Whole Exome Sequencing, Whole Genome Sequencing, Next-Generation Sequencing Gene Panel, Chromosomal Microarray Analysis	(batzir2020phenotypicexpansionof pages 12-13, batzir2020phenotypicexpansionof pages 8-9, murch2022furtherdelineationof pages 1-2)
Management	Current care is supportive and multidisciplinary: developmental/behavioral assessment, speech-language therapy, occupational/physical therapy, hearing and vision evaluation, feeding/GI support, obesity monitoring, sleep assessment (including for OSA), and seizure-directed neurology care when indicated. Published case series emphasize individualized therapies tailored to neurological, behavioral, and communication needs.	No disease-modifying drug, gene therapy, RNA therapy, or targeted therapy was identified in the gathered evidence. Treatment response rates are not established at syndrome level.	NCIT suggestions: Speech Therapy, Occupational Therapy, Physical Therapy, Behavioral Intervention, Audiologic Assessment, Ophthalmologic Examination, Nutritional Support	(batzir2020phenotypicexpansionof pages 11-12, batzir2020phenotypicexpansionof pages 1-2, murch2022furtherdelineationof pages 5-6, NCT07380594 chunk 1)
Epidemiology / prognosis	WHSUS is rare; exact population prevalence/incidence were not established in the retrieved sources. Literature available to the cohorts indicated >50 reported individuals by 2020, ~90 by 2022, and 117 patients in an aggregate genotype-phenotype analysis. Course is typically pediatric-onset and chronic/lifelong, with variable severity from mild learning/behavioral issues to severe ID and multisystem involvement. Survival/life-expectancy data were not identified; no specific excess mortality estimate was retrieved.	Prevalence, incidence, penetrance, carrier frequency, and mortality remain insufficiently defined from the gathered evidence. Long-term adult natural history remains sparse.	HPO course suggestions: Childhood onset, Chronic course, Variable expressivity	(batzir2020phenotypicexpansionof pages 1-2, nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 5-6, murch2022furtherdelineationof pages 1-2)
Trials / current research	Identified study: NCT07380594, Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome (CHU Dijon; observational; recruiting; estimated n=30; first posted 2026-02-02). It aims to define psychiatric manifestations using interviews and standardized scales in genetically confirmed individuals aged >6 years.	No interventional White-Sutton syndrome trials were identified in the gathered evidence. The located study is observational and future-dated relative to the requested 2023-2024 emphasis.	NCIT suggestions: Observational Study, Psychiatric Assessment, Questionnaire	(NCT07380594 chunk 1)
Models / comparative evidence	Best-supported model in gathered evidence: nervous-system-specific conditional Pogz knockout mouse. Reported phenotypes include microcephaly/smaller brain, growth impairment, altered embryonic neurogenesis, transcriptional dysregulation, cerebellar Purkinje-cell dysfunction, and behavioral abnormalities including learning and motor deficits, paralleling several human features. Earlier summaries also note Drosophila and possible zebrafish relevance, but detailed retrieved evidence here is strongest for mouse.	No naturally occurring veterinary disease equivalent was identified. Non-mouse models were mentioned in secondary discussion but not substantiated with detailed primary evidence in the gathered set.	Model ontology suggestions: Mus musculus; CL: Purkinje cell; UBERON: cerebellum, cerebral cortex	(batzir2020phenotypicexpansionof pages 11-12, nagy2022genotypephenotypecomparisonin pages 2-4, sulimanlavie2020pogzdeficiencyleads pages 2-3, sulimanlavie2020pogzdeficiencyleads pages 1-2)

Table: This table provides a compact knowledge-base summary of White-Sutton syndrome using only evidence gathered in this conversation. It highlights established findings, major evidence gaps, suggested ontology mappings, and supporting citations for rapid curation.

1. Disease information

Definition and identifiers

WHSUS is a Mendelian, autosomal-dominant neurodevelopmental disorder attributable to monoallelic pathogenic variants in POGZ, a chromatin-associated regulator at chromosome 1q21.3. Its clinical presentation ranges from mild learning or behavioral impairment to severe developmental disability with multisystem congenital anomalies. ClinGen/gene2phenotype evidence summarized by Open Targets classifies the POGZ–disease relationship as definitive. (batzir2020phenotypicexpansionof pages 2-3, OpenTargets Search: White-Sutton syndrome-POGZ)

OMIM: 616364.
MONDO: MONDO:0014606, labeled intellectual disability–microcephaly–strabismus–behavioral abnormalities syndrome in the retrieved mapping.
EFO/Open Targets: EFO:0009079, white-sutton syndrome.
Gene: POGZ; Ensembl ENSG00000143442; approved name pogo transposable element derived with ZNF domain.
Synonyms: POGZ-related intellectual disability syndrome; POGZ-related neurodevelopmental disorder; intellectual disability–microcephaly–strabismus–behavioral abnormalities syndrome.
Orphanet, MeSH, ICD-10/ICD-11: no verified disease-specific identifiers were recovered in the searched primary literature. In practice, nonspecific developmental-disorder, intellectual-disability, autism, epilepsy, or congenital-anomaly codes may be used, but these should not be represented as WHSUS-specific identifiers without verification.

The evidence synthesized here is principally aggregated disease-level information from published cohorts, DECIPHER/clinical laboratory series, ClinGen/Open Targets, and ClinicalTrials.gov—not an individual EHR-derived phenotype profile. The 2020 study used a genotype-first cohort and clinical laboratory database; the 2022 reports combined new individuals with literature cases. (batzir2020phenotypicexpansionof pages 1-2, murch2022furtherdelineationof pages 5-6, murch2022furtherdelineationof pages 1-2)

2. Etiology

Causal and risk factors

The primary cause is a germline heterozygous pathogenic or likely pathogenic POGZ variant. In the 22-person Batzir cohort, 18 variants were de novo, one maternally inherited, and two had unknown inheritance. In the 117-person aggregate, approximately 90% were de novo and 10% inherited. Thus, a pathogenic POGZ allele is causal rather than merely a susceptibility factor. (batzir2020phenotypicexpansionof pages 3-5, nagy2022genotypephenotypecomparisonin pages 9-10)

The predominant disease alleles are protein-truncating variants, although splice variants, whole/partial-gene deletions, in-frame deletions, and a smaller number of deleterious missense variants occur. The 117-person analysis reported nonsense 41%, frameshift 40%, missense 8.5%, splice-site 7%, large deletions 2.5%, and in-frame deletions 1%. (nagy2022genotypephenotypecomparisonin pages 9-10)

Environmental, infectious, and lifestyle factors

No toxin, infection, maternal exposure, diet, occupation, smoking, alcohol use, or other environmental factor is established as a cause of WHSUS. Lifestyle can influence secondary obesity, sleep-disordered breathing, constipation, and general health but does not cause the Mendelian disorder. No reproducible gene–environment interaction has been demonstrated.

Protective factors and modifiers

No protective POGZ allele, modifier gene, or environmental exposure that prevents WHSUS has been established. Variant position and predicted nonsense-mediated decay (NMD) behavior modify severity: truncating alleles predicted to escape NMD, particularly in the proline-rich region, were associated with more severe disease, whereas missense and NMD-subjected alleles tended to be milder. These are probabilistic cohort associations, not deterministic prognostic rules. (batzir2020phenotypicexpansionof pages 12-13, nagy2022genotypephenotypecomparisonin pages 1-2)

3. Phenotypes

The strongest frequency estimates come from differently ascertained cohorts and are not directly interchangeable. Missing data and preferential publication of severely affected patients can inflate estimates—especially the 60% seizure frequency in one selected aggregate. Murch and colleagues specifically warned of variable reporting and likely underrecognition of subtle findings. (nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 5-6)

Neurodevelopmental and behavioral manifestations

Global developmental delay—usually recognized in infancy or early childhood; variable severity, chronic/lifelong. Reported in 88% of the 117-person analysis. Suggested HPO: HP:0001263.
Speech/language delay—often especially prominent; 100% in the 22-person cohort and 88% in the 117-person analysis. Some individuals remain minimally verbal. HPO: HP:0000750, with HP:0002463 for language impairment where appropriate. (batzir2020phenotypicexpansionof pages 1-2, batzir2020phenotypicexpansionof pages 8-9, nagy2022genotypephenotypecomparisonin pages 9-10)
Motor delay—86% in the 22-person cohort; may coexist with hypotonia and gait abnormality. HPO: HP:0001270 or HP:0001263. (batzir2020phenotypicexpansionof pages 8-9)
Intellectual disability/learning difficulty—ID 87% in the 22-person series and 79% in the 117-person aggregate, but some patients have low-normal cognition or isolated learning/behavioral difficulties. Severity spans mild to severe. HPO: HP:0001249, HP:0001328. (batzir2020phenotypicexpansionof pages 11-12, nagy2022genotypephenotypecomparisonin pages 9-10)
Autism spectrum and behavior—autism was 37.5% in the 22-person series; broader behavioral abnormalities were 75% in the aggregate. Anxiety, hyperactivity/attention problems, stereotypies, social withdrawal, compulsive features, and unusually friendly behavior have been described. HPO: HP:0000717, HP:0000739, HP:0000752, HP:0000729 as individually documented. (batzir2020phenotypicexpansionof pages 8-9, nagy2022genotypephenotypecomparisonin pages 9-10, NCT07380594 chunk 1)
Hypotonia—54% in the 117-person aggregate; generally childhood onset and variable. HPO: HP:0001252. (nagy2022genotypephenotypecomparisonin pages 9-10)
Seizures/EEG abnormalities—seizures were reported in 60% in one selected aggregate, but other cohorts suggest lower or incompletely ascertained frequencies. Both epileptic and nonepileptic paroxysmal events and abnormal EEG without clinical seizures have been reported. HPO: HP:0001250, HP:0002353.
Sleep disturbance—75% in the 117-person aggregate; symptoms consistent with obstructive sleep apnea occurred in 4/12 (33%) formally screened in the 22-person cohort. HPO: HP:0002360, HP:0002870. (batzir2020phenotypicexpansionof pages 1-2, nagy2022genotypephenotypecomparisonin pages 9-10)

Growth, craniofacial, sensory, and systemic manifestations

Microcephaly: 46% in the aggregate and 8/12 in the Murch series; HPO HP:0000252. Growth may otherwise be normal, short, or overweight. (nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 1-2)
Overweight/obesity: the 2020 cohort had mean BMI z-score 0.59 and median 0.9, significantly above the reference population (p=0.0253); 4/5 patients older than ten years in the Murch series were obese. HPO HP:0025385, HP:0001513. (batzir2020phenotypicexpansionof pages 1-2, batzir2020phenotypicexpansionof pages 3-5, murch2022furtherdelineationof pages 1-2)
Facial gestalt: broad/high forehead, midface hypoplasia, broad nasal root or flat bridge, tented/triangular mouth, and sometimes low-set ears; facial dysmorphism was reported in 96% of one aggregate. These findings are usually mild and not sufficiently specific for clinical diagnosis. HPO terms should be assigned feature-by-feature rather than using a single gestalt term. (batzir2020phenotypicexpansionof pages 1-2, batzir2020phenotypicexpansionof pages 3-5, nagy2022genotypephenotypecomparisonin pages 9-10)
Ocular abnormalities: 63% in the aggregate; refractive errors, strabismus and, rarely, rod-cone dystrophy. HPO HP:0000478, HP:0000486, HP:0000510 as applicable. (nagy2022genotypephenotypecomparisonin pages 9-10, murch2022furtherdelineationof pages 5-6)
Sensorineural hearing impairment: 54% in the aggregate, although cohort ascertainment varies. HPO HP:0000407. (nagy2022genotypephenotypecomparisonin pages 9-10)
Feeding/GI: early feeding difficulty occurred in 7/11 in one series. In the 22-person cohort, swallowing difficulty occurred in 53%, gastrostomy feeding in 23.5% (4/17), cyclic vomiting in 37.5% (6/16), and severe anatomical/clinical GI complications in 16% (3/19). Constipation, reflux, dysmotility, malrotation, intussusception, pancreatitis, rectal prolapse, and congenital diaphragmatic hernia have been reported. HPO: HP:0011968, HP:0002020, HP:0002573, HP:0002019, and condition-specific terms. (batzir2020phenotypicexpansionof pages 11-12, batzir2020phenotypicexpansionof pages 7-8, murch2022furtherdelineationof pages 1-2)
Gait abnormality: common but inconsistently quantified; HPO HP:0001288.
Genitourinary anomalies: male genital anomalies occurred in 4/14 (28.6%) in one cohort; duplicated renal drainage system and other urinary anomalies are rare. HPO terms should reflect the specific defect. (batzir2020phenotypicexpansionof pages 7-8, murch2022furtherdelineationof pages 5-6)
Structural brain, cardiac, craniofacial and diaphragmatic anomalies: variably reported and usually uncommon. Major cardiovascular abnormalities were uncommon in the 2020 series; cleft lip/palate and congenital diaphragmatic hernia appear to be rare complications. (batzir2020phenotypicexpansionof pages 7-8, murch2022furtherdelineationof pages 5-6)

Quality of life

No WHSUS-specific EQ-5D, SF-36, PROMIS, or validated disease-specific quality-of-life study was identified. Developmental, communication, behavioral, sleep, feeding, sensory, mobility, and seizure manifestations can impair education, autonomy, social participation, caregiver sleep, and family well-being. This impact is clinically plausible but has not been quantified adequately in syndrome-specific prospective studies.

4. Genetic and molecular information

POGZ is the only firmly established causal gene. The retrieved evidence did not support NPC1 as a second WHSUS gene; its low Open Targets association likely reflects ontology/co-occurrence noise and should not be entered as causal. (OpenTargets Search: White-Sutton syndrome-POGZ)

Pathogenic alleles are germline and generally absent or extremely rare in population databases; POGZ is highly constrained against both protein-truncating and missense variation. Exact gnomAD frequencies must be checked variant-by-variant and were not available in the retrieved texts. Variant interpretation should follow ACMG/AMP criteria, incorporating de novo status, predicted loss of function in a constrained gene, population absence, phenotype consistency, segregation, and functional evidence. (murch2022furtherdelineationof pages 1-2)

The protein contains zinc-finger clusters, an HP1-binding motif, a proline-rich region, CENP-B DNA-binding domain, transposase-derived DDE domain, coiled-coil region, and integrase-binding motif. Many pathogenic variants occur in the large terminal exon/domain-rich region. In 117 patients, truncating alleles escaping NMD were associated with severe manifestations (p<0.0001), and variants in the proline-rich region showed the strongest severity association (p=0.0004). Missense variants were more often associated with milder disease (p=0.0421). The proposed dominant-negative or gain-of-function effect of stable truncated products remains an inference; classical haploinsufficiency remains important for alleles undergoing NMD or deletions. (batzir2020phenotypicexpansionof pages 12-13, nagy2022genotypephenotypecomparisonin pages 9-10, nagy2022genotypephenotypecomparisonin pages 1-2)

No validated modifier gene or WHSUS-specific blood DNA-methylation episignature was identified. Large deletions involving POGZ can cause the phenotype, but broader deletions require assessment for neighboring-gene effects. No repeat expansion, mitochondrial, or recurrent balanced rearrangement mechanism is established.

5. Environmental information

Environmental toxins, radiation, pollution, occupational exposure, infectious agents, smoking, alcohol, diet, and exercise are not primary etiologic factors. Diet, activity, sleep hygiene, and medications can modify obesity, constipation, sleep, and behavior after disease onset. WHSUS is neither infectious nor transmissible, and no zoonotic dimension exists.

6. Mechanism and pathophysiology

Upstream molecular defect

POGZ binds heterochromatin protein 1α and participates in chromatin organization, transcriptional regulation, chromosome segregation, kinetochore/mitotic processes, and Aurora-B-related chromosome dynamics. It also interacts with transcriptional/chromatin proteins including SP1 and CHD4 and co-occupies genomic loci with the autism-associated regulator ADNP. Expression is high during embryonic development, including fetal brain, supporting a developmental mechanism. (batzir2020phenotypicexpansionof pages 2-3, nagy2022genotypephenotypecomparisonin pages 1-2, murch2022furtherdelineationof pages 1-2)

Causal chain

Pathogenic POGZ allele → reduced normal POGZ dosage and/or abnormal stable truncated protein → impaired HP1-associated heterochromatin and transcriptional control, altered mitotic/neural-progenitor programs and synaptic-gene accessibility → abnormal neurogenesis and neuronal circuit maturation → cerebellar/cortical dysfunction → developmental, cognitive, motor, behavioral, seizure, and sleep phenotypes. Pleiotropic transcriptional effects during embryogenesis plausibly contribute to craniofacial, GI, genitourinary, diaphragmatic, and other congenital anomalies, but these extra-neural links are less directly established.

Model and cellular evidence

In a nervous-system-specific conditional mouse knockout, Pogz deficiency produced smaller absolute brain size, growth impairment, learning and motor deficits, and altered sociability. Embryonic cortex showed a 19% reduction in mitotic pHH3-positive cells in heterozygotes and 43.8% in homozygotes, with expansion of the Tbr2-positive intermediate-progenitor layer but no significant change in Pax6-positive apical progenitors. Complete germline knockout is embryonic lethal, limiting direct correspondence to viable heterozygous humans. (sulimanlavie2020pogzdeficiencyleads pages 2-3, sulimanlavie2020pogzdeficiencyleads pages 1-2)

Transcriptomic changes were predominantly gene upregulation—most marked in cerebellum—and enriched for neurogenesis, synaptic, and autism-related pathways. Cerebellar Purkinje cells showed reduced simple- and complex-spike firing and increased inhibitory synaptic-input amplitude. The authors’ abstract states: “Our findings support a mechanism linking heterochromatin dysregulation to cerebellar circuit dysfunction and behavioral abnormalities in ASD.” This is primary mouse/in-vitro evidence, not direct proof that every human manifestation is cerebellar in origin. Published 2020-11-17, DOI: https://doi.org/10.1038/s41467-020-19577-0. (sulimanlavie2020pogzdeficiencyleads pages 1-2)

Suggested annotations include GO chromatin organization, negative regulation of transcription by RNA polymerase II, mitotic chromosome segregation, neurogenesis, regulation of synaptic signaling, and heterochromatin organization; cellular components include nucleus, chromatin, heterochromatin, and kinetochore. Relevant Cell Ontology classes include Purkinje cell, neuron, cortical neural progenitor cell, and intermediate progenitor cell. No validated human metabolomic, lipidomic, proteomic, single-cell, spatial-transcriptomic, or multi-omic WHSUS signature was found through 2024.

7. Anatomical structures affected

The primary system is the nervous system, particularly the developing brain. Relevant locations include cerebral cortex (UBERON:0000956), cerebellum (UBERON:0002037), hippocampal formation, and their neuronal progenitors and mature neurons. Mouse evidence most directly implicates cortical progenitors and cerebellar Purkinje cells. (sulimanlavie2020pogzdeficiencyleads pages 2-3, sulimanlavie2020pogzdeficiencyleads pages 1-2)

Secondary involvement can include eyes/visual system, inner ear/auditory system, skeletal muscle or motor system through hypotonia, gastrointestinal tract, upper airway during sleep, kidney/urinary and reproductive systems, craniofacial structures, and—rarely—diaphragm, heart, or brain structure. Ocular and hearing abnormalities are frequently bilateral, but no consistent lateralization pattern is established. At the subcellular level, the nucleus, chromatin/heterochromatin, chromosomes, and kinetochore are principal compartments.

8. Temporal development

WHSUS is congenital in molecular origin and typically becomes clinically apparent during infancy or early childhood through hypotonia, feeding difficulty, delayed milestones, poor speech acquisition, microcephaly, or congenital anomalies. Some mildly affected people are diagnosed later through learning, psychiatric, or behavioral assessment. The 2020 cohort’s median diagnostic age was eight years, with a range from one week to 28 years, demonstrating diagnostic delay and broad ascertainment. (batzir2020phenotypicexpansionof pages 3-5)

The course is chronic and lifelong, not acute, relapsing-remitting, or self-limited. Developmental skills may improve with maturation and therapy, but core neurodevelopmental disability does not “remit.” Obesity may become more apparent later in childhood; seizures, sleep apnea, behavior, and GI problems may be episodic or evolve over time. No validated staging system or progression rate exists. Early childhood is the principal intervention window for speech, motor, communication, feeding, sensory, and behavioral support.

9. Inheritance and population

Inheritance is autosomal dominant, predominantly de novo. Vertical transmission demonstrates that affected individuals can reproduce; a carrier parent may be only mildly affected. Penetrance cannot be quantified reliably, although pathogenic truncating alleles generally appear clinically consequential. Expressivity is markedly variable. There is no evidence for anticipation, founder mutations, consanguinity dependence, or a population-specific carrier frequency. Parental germline mosaicism has not been quantified; as with other apparently de novo dominant disorders, a low residual recurrence risk should be discussed after negative parental blood testing.

No population prevalence or annual incidence estimate is established. The literature had reported more than 50 affected people by 2020, nearly 90 by 2021/2022, and 117 individuals were available for the large 2022 aggregate. POGZ diagnoses accounted for approximately 0.14% of clinical exomes referred for neurodevelopmental indications in one laboratory dataset, including 0.12% of autism, 0.19% of developmental-delay, and 0.18% of intellectual-disability referrals. These are diagnostic-laboratory yields, not population prevalence. (batzir2020phenotypicexpansionof pages 1-2, batzir2020phenotypicexpansionof pages 12-13, nagy2022genotypephenotypecomparisonin pages 9-10)

No robust ethnic, geographic, or sex disparity is established. The 117-person analysis included 62 males and 53 females with two sex entries apparently unavailable, broadly consistent with no major sex bias. (nagy2022genotypephenotypecomparisonin pages 2-4)

10. Diagnostics

Recommended testing strategy

Clinical recognition: unexplained developmental/speech delay or ID, especially with hypotonia, autism/behavioral features, visual problems, microcephaly, hearing loss, feeding/GI difficulty, sleep disorder, or suggestive facial appearance.
First-line genomic test: trio WES or WGS is preferred for a nonspecific syndromic neurodevelopmental presentation. A comprehensive neurodevelopmental/ID/autism panel containing POGZ is appropriate where exome/genome sequencing is unavailable.
Variant confirmation and segregation: confirm the candidate variant and test both biological parents. Sanger sequencing remains useful for segregation; read-depth/CNV analysis is needed for exon or whole-gene deletions.
CMA: useful when congenital anomalies or ID suggest a copy-number disorder and can identify a deletion encompassing POGZ, but will miss most single-nucleotide and small indel alleles.
WGS: potentially detects coding variants, CNVs, structural variants, and noncoding/splice-altering variants missed by WES; evidence for a WHSUS-specific incremental yield has not yet been quantified.

Most reported individuals were diagnosed by trio WES, WGS, or an ID gene panel because the phenotype is insufficiently specific for reliable clinical diagnosis. (murch2022furtherdelineationof pages 1-2)

Karyotyping/FISH are not routine unless a larger rearrangement is suspected. Mitochondrial sequencing, repeat-expansion testing, biopsy, metabolomics, proteomics, and liquid biopsy have no disease-specific role. RNA sequencing may help resolve an uncertain splice variant but is not validated as routine WHSUS testing. No standardized clinical diagnostic criteria or biochemical biomarker exists.

Baseline and surveillance evaluations

After molecular diagnosis: developmental/neuropsychological evaluation; speech-language and feeding/swallow assessment; growth and BMI; ophthalmology; audiology; neurologic examination; EEG if seizures or suspicious events occur; sleep evaluation/polysomnography when snoring, apnea, or daytime symptoms occur; and GI, renal, cardiac, or brain imaging guided by findings. Routine MRI in an asymptomatic patient is not supported by a syndrome-specific guideline.

Differential diagnoses include other chromatin-related syndromic neurodevelopmental disorders—particularly ADNP-related Helsmoortel–Van der Aa syndrome, CHAMP1-related disorder, KBG syndrome, Coffin-Siris spectrum, Wiedemann-Steiner syndrome, and CHD8-related disorder—as well as Angelman, Smith-Magenis, and nonsyndromic autism/ID. Molecular testing is usually required to distinguish them.

11. Outcome and prognosis

No 5- or 10-year survival, disease-specific mortality, or life-expectancy estimate is available. Available adult and inherited cases indicate survival into adulthood, but cohorts are too young and small for reassurance about normal life expectancy. Morbidity is primarily neurodevelopmental and functional rather than degenerative: communication disability, learning/ID, behavioral or psychiatric comorbidity, hypotonia/gait difficulty, sensory impairment, sleep apnea, obesity, feeding/GI problems, and seizures.

Recovery to a completely unaffected state is not expected, although functional gains can occur with education, therapy, communication support, seizure control, sensory correction, nutritional intervention, and treatment of sleep apnea or GI disease. Variant class/NMD behavior may inform broad severity expectations, but no prognostic biomarker or validated individual prediction model exists. (batzir2020phenotypicexpansionof pages 12-13, nagy2022genotypephenotypecomparisonin pages 1-2)

12. Treatment

There is no approved disease-modifying pharmacotherapy, gene therapy, cell therapy, RNA therapy, or POGZ-targeted therapy. Management is phenotype based:

early-intervention services and individualized education;
speech-language therapy, including augmentative and alternative communication;
physical and occupational therapy for hypotonia, motor delay, gait, and daily-living skills;
behavioral therapy and child/adult psychiatry for autism, anxiety, ADHD-like symptoms, compulsive behavior, aggression, or sleep-related behavior;
conventional antiseizure medication selected by seizure type;
hearing aids/cochlear or other audiologic intervention where indicated;
glasses, strabismus treatment, and retinal follow-up where indicated;
feeding therapy, swallow-safety measures, reflux/constipation treatment, nutrition support, and gastrostomy for severe feeding impairment;
sleep hygiene, polysomnography, ENT evaluation, adenotonsillar treatment or positive-airway pressure for confirmed obstructive sleep apnea;
healthy diet, activity support, and longitudinal BMI/metabolic monitoring;
anomaly-specific surgical care, such as for malrotation, diaphragmatic hernia, clefting, or urinary defects.

Suggested NCIt intervention concepts include Speech Therapy, Occupational Therapy, Physical Therapy, Behavior Therapy, Anticonvulsant Therapy, Hearing Aid, Nutritional Support, Gastrostomy, and Continuous Positive Airway Pressure. There are no syndrome-specific response-rate or adverse-event datasets and no evidence-based combination algorithm.

The only disease-specific registered study recovered was NCT07380594 (PSY-POGZ), a prospective observational—not therapeutic—study at CHU Dijon. It plans 30 genetically confirmed participants aged over six years and uses psychiatric interviews and standardized K-SADS/MINI instruments; it was first posted February 2, 2026 and is therefore outside the requested 2023–2024 priority window. (NCT07380594 chunk 1)

13. Prevention

A sporadic de novo pathogenic variant cannot ordinarily be prevented through behavioral or environmental modification. There is no vaccine, medication prophylaxis, newborn biochemical screening, or population screening program.

Primary reproductive prevention options are nondirective genetic counseling, prenatal diagnosis for a known familial variant, and preimplantation genetic testing for monogenic disease. For an apparently de novo case, parental testing refines recurrence counseling but does not eliminate the possibility of germline mosaicism. An affected heterozygous parent has a theoretical 50% transmission probability per pregnancy, with unpredictable severity because of variable expressivity.

Secondary/tertiary prevention consists of early genomic diagnosis, developmental intervention, seizure safety, hearing and vision screening, aspiration prevention, sleep-apnea recognition, weight management, and surveillance/treatment of GI or congenital complications. Cascade testing is appropriate in families with an inherited variant; general-population carrier screening is not justified.

14. Other species and natural disease

No naturally occurring WHSUS-equivalent disease in companion animals, livestock, or wildlife was identified, and no breed association or VBO term can currently be recommended. POGZ is evolutionarily conserved and orthologs exist in common research organisms, but comparative conservation alone is not evidence of naturally occurring veterinary disease. There is no transmission or zoonotic potential.

15. Model organisms

The best-characterized model is Mus musculus (NCBI Taxonomy 10090) with nervous-system-specific conditional Pogz deletion driven by Nestin-Cre. It recapitulates smaller brain, growth impairment, altered neurogenesis, learning and motor deficits, altered sociability, cerebellar transcriptional dysregulation, and Purkinje-cell physiology. Relevant applications include testing the consequences of dosage reduction on neural progenitors, chromatin/transcription, synaptic pathways, cerebellar circuitry, and behavior. (sulimanlavie2020pogzdeficiencyleads pages 2-3, sulimanlavie2020pogzdeficiencyleads pages 1-2)

Important limitations are that homozygous nervous-system knockout is more severe than the typical human heterozygous state, complete germline knockout is embryonic lethal, mouse sociability is not equivalent to human autism, and the model does not reliably reproduce the full human multisystem phenotype. Earlier literature mentions Drosophila and zebrafish approaches, but detailed primary evidence retrieved for this report was insufficient to specify validated WHSUS phenotypic recapitulation. (batzir2020phenotypicexpansionof pages 11-12, nagy2022genotypephenotypecomparisonin pages 2-4)

Recent-development assessment and evidence gaps

Through 2024, the principal advances were refinement of genotype–phenotype relationships, recognition of inherited/mild disease and rare multisystem complications, and increasingly cell-type-specific mouse studies. The core 2022 result is captured directly in the authors’ abstract: “Missense variants were more often associated with mild phenotypes (p = 0.0421) and truncating variants predicted to escape NMD presented with more severe phenotypes (p < 0.0001).” Nagy et al., published January 15, 2022, DOI: https://doi.org/10.3390/genes13010154. (nagy2022genotypephenotypecomparisonin pages 1-2)

The key unresolved needs are a prospective multinational natural-history registry; standardized developmental, psychiatric, sleep, seizure, GI, and quality-of-life measures; adult outcome and mortality data; variant-level functional assays; human iPSC/organoid studies; human single-cell and multi-omic profiling; validated biomarkers; and preclinical evaluation of dosage-restoring or transcript-specific therapies. The currently available frequency estimates should therefore be treated as provisional rather than population-level penetrance figures.

References

(batzir2020phenotypicexpansionof pages 1-2): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(OpenTargets Search: White-Sutton syndrome-POGZ): Open Targets Query (White-Sutton syndrome-POGZ, 4 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(murch2022furtherdelineationof pages 1-2): Oliver Murch, Vani Jain, Andreas Benneche, Kay Metcalfe, Emma Hobson, Katrina Prescott, Kate Chandler, Neeti Ghali, Jenny Carmichael, Nicola C. Foulds, Julie Paulsen, Marie F. Smeland, Siren Berland, and Andrew E. Fry. Further delineation of the clinical spectrum of white–sutton syndrome: 12 new individuals and a review of the literature. European Journal of Human Genetics, 30:95-100, Oct 2022. URL: https://doi.org/10.1038/s41431-021-00961-3, doi:10.1038/s41431-021-00961-3. This article has 22 citations and is from a domain leading peer-reviewed journal.
(batzir2020phenotypicexpansionof pages 3-5): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(nagy2022genotypephenotypecomparisonin pages 9-10): Dóra Nagy, Sarah Verheyen, Kristen M. Wigby, Artem Borovikov, Artem Sharkov, Valerie Slegesky, Austin Larson, Christina Fagerberg, Charlotte Brasch-Andersen, Maria Kibæk, Ingrid Bader, Rebecca Hernan, Frances A. High, Wendy K. Chung, Jolanda H. Schieving, Jana Behunova, Mateja Smogavec, Franco Laccone, Martina Witsch-Baumgartner, Joachim Zobel, Hans-Christoph Duba, and Denisa Weis. Genotype-phenotype comparison in pogz-related neurodevelopmental disorders by using clinical scoring. Genes, 13:154, Jan 2022. URL: https://doi.org/10.3390/genes13010154, doi:10.3390/genes13010154. This article has 33 citations.
(batzir2020phenotypicexpansionof pages 12-13): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(nagy2022genotypephenotypecomparisonin pages 1-2): Dóra Nagy, Sarah Verheyen, Kristen M. Wigby, Artem Borovikov, Artem Sharkov, Valerie Slegesky, Austin Larson, Christina Fagerberg, Charlotte Brasch-Andersen, Maria Kibæk, Ingrid Bader, Rebecca Hernan, Frances A. High, Wendy K. Chung, Jolanda H. Schieving, Jana Behunova, Mateja Smogavec, Franco Laccone, Martina Witsch-Baumgartner, Joachim Zobel, Hans-Christoph Duba, and Denisa Weis. Genotype-phenotype comparison in pogz-related neurodevelopmental disorders by using clinical scoring. Genes, 13:154, Jan 2022. URL: https://doi.org/10.3390/genes13010154, doi:10.3390/genes13010154. This article has 33 citations.
(batzir2020phenotypicexpansionof pages 11-12): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(batzir2020phenotypicexpansionof pages 7-8): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(batzir2020phenotypicexpansionof pages 8-9): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(murch2022furtherdelineationof pages 5-6): Oliver Murch, Vani Jain, Andreas Benneche, Kay Metcalfe, Emma Hobson, Katrina Prescott, Kate Chandler, Neeti Ghali, Jenny Carmichael, Nicola C. Foulds, Julie Paulsen, Marie F. Smeland, Siren Berland, and Andrew E. Fry. Further delineation of the clinical spectrum of white–sutton syndrome: 12 new individuals and a review of the literature. European Journal of Human Genetics, 30:95-100, Oct 2022. URL: https://doi.org/10.1038/s41431-021-00961-3, doi:10.1038/s41431-021-00961-3. This article has 22 citations and is from a domain leading peer-reviewed journal.
(batzir2020phenotypicexpansionof pages 2-3): Nurit Assia Batzir, Jennifer E. Posey, Xiaofei Song, Zeynep Coban Akdemir, Jill A. Rosenfeld, Chester W. Brown, Emily Chen, Shannon G. Holtrop, Elizabeth Mizerik, Margarita Nieto Moreno, Katelyn Payne, Annick Raas‐Rothschild, Richard Scott, Hilary J. Vernon, Neda Zadeh, James R. Lupski, and V. Reid Sutton. Phenotypic expansion of pogz‐related intellectual disability syndrome (white‐sutton syndrome). American Journal of Medical Genetics Part A, 182:38-52, Nov 2020. URL: https://doi.org/10.1002/ajmg.a.61380, doi:10.1002/ajmg.a.61380. This article has 70 citations.
(sulimanlavie2020pogzdeficiencyleads pages 1-2): Reut Suliman-Lavie, Ben Title, Yahel Cohen, Nanako Hamada, Maayan Tal, Nitzan Tal, Galya Monderer-Rothkoff, Bjorg Gudmundsdottir, Kristbjorn O. Gudmundsson, Jonathan R. Keller, Guo-Jen Huang, Koh-ichi Nagata, Yosef Yarom, and Sagiv Shifman. Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice. Nature Communications, Nov 2020. URL: https://doi.org/10.1038/s41467-020-19577-0, doi:10.1038/s41467-020-19577-0. This article has 67 citations and is from a highest quality peer-reviewed journal.
(sulimanlavie2020pogzdeficiencyleads pages 2-3): Reut Suliman-Lavie, Ben Title, Yahel Cohen, Nanako Hamada, Maayan Tal, Nitzan Tal, Galya Monderer-Rothkoff, Bjorg Gudmundsdottir, Kristbjorn O. Gudmundsson, Jonathan R. Keller, Guo-Jen Huang, Koh-ichi Nagata, Yosef Yarom, and Sagiv Shifman. Pogz deficiency leads to transcription dysregulation and impaired cerebellar activity underlying autism-like behavior in mice. Nature Communications, Nov 2020. URL: https://doi.org/10.1038/s41467-020-19577-0, doi:10.1038/s41467-020-19577-0. This article has 67 citations and is from a highest quality peer-reviewed journal.
(NCT07380594 chunk 1): Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome. Centre Hospitalier Universitaire Dijon. 2026. ClinicalTrials.gov Identifier: NCT07380594
(nagy2022genotypephenotypecomparisonin pages 2-4): Dóra Nagy, Sarah Verheyen, Kristen M. Wigby, Artem Borovikov, Artem Sharkov, Valerie Slegesky, Austin Larson, Christina Fagerberg, Charlotte Brasch-Andersen, Maria Kibæk, Ingrid Bader, Rebecca Hernan, Frances A. High, Wendy K. Chung, Jolanda H. Schieving, Jana Behunova, Mateja Smogavec, Franco Laccone, Martina Witsch-Baumgartner, Joachim Zobel, Hans-Christoph Duba, and Denisa Weis. Genotype-phenotype comparison in pogz-related neurodevelopmental disorders by using clinical scoring. Genes, 13:154, Jan 2022. URL: https://doi.org/10.3390/genes13010154, doi:10.3390/genes13010154. This article has 33 citations.

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Imaging Findings

Progression

Prevalence

Differential Diagnoses

Clinical Trials

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

White-Sutton Syndrome: Disease Characteristics Research Report

Executive summary

1. Disease information

Definition and identifiers

2. Etiology

Causal and risk factors

Environmental, infectious, and lifestyle factors

Protective factors and modifiers

3. Phenotypes

Neurodevelopmental and behavioral manifestations

Growth, craniofacial, sensory, and systemic manifestations

Quality of life

4. Genetic and molecular information

5. Environmental information

6. Mechanism and pathophysiology

Upstream molecular defect

Causal chain

Model and cellular evidence

7. Anatomical structures affected

8. Temporal development

9. Inheritance and population

10. Diagnostics

Recommended testing strategy

Baseline and surveillance evaluations

11. Outcome and prognosis

12. Treatment

13. Prevention

14. Other species and natural disease

15. Model organisms

Recent-development assessment and evidence gaps

Artifacts